>0:  2 100.0% 100.0% 1:341
MDLSSQEYDPSQFCFPAVNNSCLKGTHHVSTQTVVYLILASAMTVTVLGNSVVIISIAHFKQLQTPTNIL
VMSLALADLLLGLVVMPFSMIRSVDGCWYYGETFCLLHTGFDLFLTSVSIFHLIFIAVDRHQAVCFPLQY
PTRITIPVAWVMVMISWSMAAFYSYGVVYSKANLEGLEEYIASVYCMGGCTLYFNALWSVLDTLLTFFLP
CSVMVGLYARIFVVAKKHIKSITEANQNENENVFKNPRRSERKAAKTLGIVVGAFILCWLPFFINSLVDP
YINFSTPYALFDAFGWLGYTNSTLNPIIYGLFYPWFRKTLSLIVTLRIFEPNSSDINLFTV
>1:Q5QNP2 Trace amine-associated receptor 13c OS=Danio rerio OX=7955 GN=taar13c PE=1 SV=1 2 382 6e-132 1 100.0% 100.0% 1:341 1:341
MDLSSQEYDPSQFCFPAVNNSCLKGTHHVSTQTVVYLILASAMTVTVLGNSVVIISIAHFKQLQTPTNIL
VMSLALADLLLGLVVMPFSMIRSVDGCWYYGETFCLLHTGFDLFLTSVSIFHLIFIAVDRHQAVCFPLQY
PTRITIPVAWVMVMISWSMAAFYSYGVVYSKANLEGLEEYIASVYCMGGCTLYFNALWSVLDTLLTFFLP
CSVMVGLYARIFVVAKKHIKSITEANQNENENVFKNPRRSERKAAKTLGIVVGAFILCWLPFFINSLVDP
YINFSTPYALFDAFGWLGYTNSTLNPIIYGLFYPWFRKTLSLIVTLRIFEPNSSDINLFTV
>2:Q5QD12 Trace amine-associated receptor 7a OS=Mus musculus OX=10090 GN=Taar7a PE=2 SV=1 2 317 6e-106 1 99.1% 42.5% 1:339 16:356
MNEDLFSATSTELCYENLNRSCVRSPYSPGPRLILYAVFGFGAALAVCGNLLVMTSILHFRQLHSPANFL
VASLACADFLVGLTVMPFSTVRSVEGCWYFGESYCKFHSCFEGSFCYSSIFHLCFISVDRYIAVSDPLTY
PTRFTASVSGKCITFSWLLSIIYSFSLLYTGANEAGLEDLVSVLTCVGGCQIAVNQSW-VFINFLLFLIP
TLVMMTVYSKIFLIAKQQAQNIEKMSkrASESYKDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDA
FLGFITPTYVYEILVWIAYYNSAMNPLIYAFFYPWFRKAIKLIVTGKILRENSSTTNLF--
>3:Q5QD11 Trace amine-associated receptor 7b OS=Mus musculus OX=10090 GN=Taar7b PE=2 SV=1 2 315 2e-105 1 97.4% 42.9% 7:339 22:356
------SATSTELCYENLNRSCVRSPYSPGPRLILYAVFGFGAALAVCGNLLVMTSILHFRQLHSPANFL
VVSLACADFLVGLTVMPFSTVRSVEGCWYFGESYCKLHTCFDVSFCYCSIFHLCFISVDRYIAVSDPLTY
PTRFTAFVSGKCITFSWLLSTIYGFSLLYTGANEAGLEDLVSALTCVGGCQLAVNQSW-VFINFLLFLIP
TLVMITVYSKIFLIAKQQAQNIEKMSkrASDSYKDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDA
FLGFITPTYVYEILVWIAYYNSAMNPLIYAFFYPWFRKAIKLIVSGKVLRENSSTTNLF--
>4:Q923X8 Trace amine-associated receptor 7b OS=Rattus norvegicus OX=10116 GN=Taar7b PE=3 SV=2 2 315 5e-105 1 97.4% 43.2% 7:339 22:356
------SASSMQLCYEKLNRSCVRSPYSPGPRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPANFL
VASLACADFLVGLTVMPFSMVRSVEGCWYFGDIYCKFHSSFDGSFCYSSIFHLCFISADRYIAVSDPLIY
PTRFTASVSGKCITFSWLLSIIYSFSLFYTGVNEAGLEDLVSALTCVGGCQIAVNQSW-VFINFLLFLVP
ALVMMTVYSKIFLIAKQQAQNIEKMGkrASESYKDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDA
FLGFVTPTYVYEILVWIGYYNSAMNPLIYAFFYPWFRKAIKLIVTGKILRENSSATNLF--
>5:Q923Y6 Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=3 SV=1 2 313 1e-104 1 96.2% 46.5% 12:340 2:332
-----------ELCYENVNGSCIKSSYSPWPRAILYAVLGLGALLAVFGNLLVITAILHFKQLHTPTNFL
VASLACADFLVGVTVMPFSTVRSVEGCWYFGDTYCKFHTCFDTSFCFASLFHLCCISIDRYVAVTDPLTY
PTKFTISVSGVCIALSWFFSVTYSFSIFYTGANEEGIEELVVALTCVGGCQAPLNQNWVLLCFLLF-FLP
TVVMVFLYGRIFLVAKQQARKiaNQPQASSESYKERVARRERKAAKTLGIAMAAFLVSWLPYIIDAVIDA
YMNFITPAYVYEILVWCVYYNSAMNPLIYAFFYPWFRKAIKLIVSGKVFRADSSRTNLFS-
>6:Q5QD04 Trace amine-associated receptor 9 OS=Mus musculus OX=10090 GN=Taar9 PE=2 SV=1 2 313 2e-104 1 99.4% 44.7% 1:340 1:342
MTSDFSPEPPMELCYENVNGSCIKSSYAPWPRAILYGVLGLGALLAVFGNLLVIIAILHFKQLHTPTNFL
VASLACADFLVGVTVMPFSTVRSVESCWYFGESYCKFHTCFDTSFCFASLFHLCCISIDRYIAVTDPLTY
PTKFTVSVSGLCIALSWFFSVTYSFSIFYTGANEEGIEELVVALTCVGGCQAPLNQNWVLLCFLLF-FLP
TVVMVFLYGRIFLVAKYQARKiaNQAQASSESYKERVAKRERKAAKTLGIAMAAFLVSWLPYIIDAVIDA
YMNFITPAYVYEILVWCVYYNSAMNPLIYAFFYPWFRKAIKLIVSGKVFRADSSTTNLFS-
>7:Q923Y2 Trace amine-associated receptor 7a OS=Rattus norvegicus OX=10116 GN=Taar7a PE=3 SV=1 2 313 3e-104 1 99.1% 42.8% 1:339 16:356
MSEDLLSASSPQLCYENLNGSCIRSPYSPGPRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPANFL
VASLACADFLVGLTVMPFSTVRSVEGCWYFGDTYCKFHSCFEGSFCYSSIFHLCFISVDRYIAVSDPLIY
PTRFTASVSGKCITFSWLLSIIYSFSLLYTGANEAGLEDLVSALTCVGGCQIAVNQSW-VFINFLLFLVP
TLVMMTVYSKIFLIAKQQAQNIEKMSkrASESYKDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDA
FLGFITPTYVYEILVWIAYYNSAMNPLIYAFFYPWFRKAIKLIVTGKILRQNSSVTNLF--
>8:Q5QD09 Trace amine-associated receptor 7e OS=Mus musculus OX=10090 GN=Taar7e PE=2 SV=1 2 312 5e-104 1 97.4% 43.2% 7:339 22:356
------SATSAELCYENLNRSCVRSPYSPGPRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPANFL
VASLACADFLVGLTVMPFSTVRSVEGCWYFGEIYCKLHTCFDVSFCSSSIFHLCFISVDRYIAVSDPLIY
PTRFTASVSNKCITFSWLLSISYGFSLIYTGASEAGLEDLVSALTCVGGCQLAVNQSW-VFINFLLFLIP
TLVMITVYSKIFLIAKQQAQNIEKMSkrASDSYKDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSFIDA
FLGFITPTYVYEILVWIAYYNSAMNPLIYAFFYPWFRKAIKLTVTGKILRENSSTTNLF--
>9:Q5QD10 Trace amine-associated receptor 7d OS=Mus musculus OX=10090 GN=Taar7d PE=2 SV=1 2 311 9e-104 1 97.4% 42.0% 7:339 22:356
------SATSTELCYENLNRSCVRSPYSPGPRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPANFL
VASLACADFLVGVMVMPFSMVRSVEGCWYFGESYCKFHSCFEGSFCYSSLFHLCFISVDRYIAVSDPLTY
PTRFTASVSGKCITFSWLLSIIYSFSLLYTGANDAGLEDLVSALTCVGGCQIAVNQTW-VFINFLLFLIP
TLVMITVYSKIFLIAKQQAQNIEKMSkrASESYKDRVTKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDA
FLGFITPTYVYEILVWIVYYNSAMNPLIYAFFYSWFRKAIKLIVSGKILRENSSTTNLF--
>10:Q923Y1 Trace amine-associated receptor 7g OS=Rattus norvegicus OX=10116 GN=Taar7g PE=3 SV=1 2 311 2e-103 1 95.9% 43.6% 12:339 27:356
-----------QLCYENLNRSCVRSPYSPGSRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPANFL
VASLACADLLVGLTVMPFSMVRSVEGCWYFGDSYCKLHSCFDISFCSSSLLHLCFISVDRHIAVSDPLIY
PTRFTASVSGKYITFSWLLSIIYGFSLIYTGASEAGLEDLVSALTCVGGCQVAVNQSW-VFINFLLFLVP
ALVMMTVYSKIFLIAKQQAQNMEKMSkrASDSYKDRVAKRERKAAKTLGIAVAAFLLSWLPYFVDSIIDA
FLGFITPTYVYEILAWIAYYNSAMNPLIYAFFYPWFRKAIKLIVTGKILKENSSTINLF--
>11:Q923X6 Trace amine-associated receptor 7e OS=Rattus norvegicus OX=10116 GN=Taar7e PE=3 SV=1 2 310 3e-103 1 96.5% 43.6% 10:339 25:356
---------SSQLCYENLNRSCIRSPYSPGPRLILHAVFGFSAVLAVCGNLLVMTSILHFRQLHSPANFL
VASLACADLLVGLTVMPFSMVRSVEGCWYFGDIYCKFHSSFDVSFCYSSIFHLCFISVDRYIAVSDPLIY
LTRFTASVSGKCITFSWFLSIIYSFSLLYTGASEAGLEDLVSALTCVGGCQLAVNQSW-VFINFLLFLVP
TLVMMTVYSKVFLIAKQQAQNIEKIGkrASESYKDRVAKRERKAAKTLGITVAAFLLSWLPYFIDSIIDA
FLGFITPTYVYEILVWIAYYNSAMNPLIYAFFYPWFRKAIKLIVTGKILRENSSATNLF--
>12:Q923X5 Trace amine-associated receptor 7d OS=Rattus norvegicus OX=10116 GN=Taar7d PE=3 SV=1 2 309 1e-102 1 97.4% 43.2% 7:339 22:356
------SASSLQLCYENLNRSCVRSPYSPGPRLILYAVFGFGAVLAVCGNLMVMTSILHFRQLHSPANFL
VASLACADFLVGLTVMPFSMVRSVEGCWYFGDTYCKLHTCFDVSFCYCSLFHLCFISVDRYIAVSDPLIY
PTRFTASVSGKCITFSWLLSIIYGFPLIYTGASEAGLEDLVSALTCVGGCQIPMNQKFVLINFLL-FLVP
TLVMMTVYSKIFLIARQQAQNIEKMRkrASESYKDRVCKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDA
FLGFITPTYVYEILIWIVYYNSSMNPLIYAFFYPWFRKATKLIVTGKILRENSSTINLF--
>13:Q5QD21 Trace amine-associated receptor 7c OS=Rattus norvegicus OX=10116 GN=Taar7c PE=3 SV=1 2 308 2e-102 1 97.4% 43.2% 7:339 22:356
------SASSLQLCYENLNRSCVRSPYSPGSRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPANFL
VASLACADLLVGLTVMPFSMVRSVEGCWYFGNTYCKFHSCFEGSFCYSSLFHLCFISLDRYIAVSDPLIY
PTRFTASISGKCITFSWLLSIIYSFSLLYTGANEAGLEDLVSALTCVGGCQVAVNQSW-VFINFLLFLVP
ALVMMTVYSKIFLIAKQQAQNIEKMSkrASESYKDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSIIDA
FLGFITPTYMYEILVWIVYYNSAMNPLIYAFFYPWFRKAIKLIVTGKILRENSSTINLF--
>14:Q5QD08 Trace amine-associated receptor 7f OS=Mus musculus OX=10090 GN=Taar7f PE=2 SV=1 2 307 4e-102 1 97.7% 41.9% 7:340 22:357
------SATSAELCYENLNRSCVRSPYSPGPRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPANFL
VASLACADFLVGVMVMPFSMVRSVEGCWYFGDSYCKLHTCFDVSFCYCSLFHLCFISVDRYIAVSDPLAY
PTRFTASVSGKCITFSWLLSISYGFSLIYTGASEAGLEDLVSSLTCVGGCQIAVNQTW-VFINFSVFLIP
TLVMITVYSKIFLIAKQQAQNIEKMSkrASDSYKDRVAKRERKAAKTLGIAVAAFLLSWLPYFIDSFIDA
FLGFITPTYVYEILVWIVYYNSAMNPLIYAFFYPWFRKAIKLTVTGKILRENSSTTNLFS-
>15:Q923Y7 Trace amine-associated receptor 4 OS=Rattus norvegicus OX=10116 GN=Taar4 PE=3 SV=1 2 305 2e-101 1 96.5% 51.7% 11:339 12:343
----------TQFCFAAANNSCPRKARPALVVCAMYLVMIGAIVMTMLGNMVVIISIAHFKQLHSPTNFL
ILSMATTDFLLSCVVMPFSMVRSIESCWYFGDLFCKVHSCCDIMLCTTSIFHLCFISVDRHYAVCDPLHY
VTQITVGVVGVFLLISWSVPILFAFGLVFSELNLIGAEDFVAAIDCTGLCVLIFNKLWGVLASFIAFFLP
GAIMVGIYIHIFTVARKHARKIGPGPRTksESKMKATSGKESKATKTLSIVMGVFVLCWLPFFVLTITDP
FIGFTTPEDLYNVFLWLGYFNSTFNPIIYGMFYPWFRKALRMIVTGTIFRSDSSTSSLH--
>16:Q5QD15 Trace amine-associated receptor 4 OS=Mus musculus OX=10090 GN=Taar4 PE=2 SV=1 2 303 1e-100 1 96.2% 52.4% 12:339 13:343
-----------QFCFAAANSSCPRKARPALVVCAMYLIMIGAIVMTMLGNMAVIISIAHFKQLHSPTNFL
ILSMATTDFLLSCVVMPFSMIRSIESCWYFGDLFCKVHSCCDIMLCTTSIFHLCFISVDRHYAVCDPLHY
VTQITTRVVGVFLLISWSVPIFFAFGLVFSELNLIGAEDFVAAIDCTGLCVLIFNKLWGVLASFIAFFLP
GTVMVGIYIHIFTVAQKHARQIGTGPRTKqeSKMKATSKKESKATKTLSIVMGVFVLCWLPFFVLTITDP
FIDFTTPEDLYNVFLWLGYFNSTFNPIIYGMFYPWFRKALRMIVTGTIFRSDSSTSSLH--
>17:Q923Y4 Trace amine-associated receptor 7h OS=Rattus norvegicus OX=10116 GN=Taar7h PE=3 SV=1 2 302 3e-100 1 96.2% 41.9% 12:340 27:357
-----------QLCYENLNRSCVRSPYSPGPRLILYAVFGFGAVLAVCGNLLVMTSILHFRQLHSPANFL
VASLACADLLVGLTVMPFSMVRSVEGCWYFGDSYCKLHTSFDMSFCCSSLLHLCFISVDRYIAVSDPLIY
PIRFTASVSGKCITFSWFLSIIYGFSLIYTGASEAGLKDLVSALSCVGGCQIPMNQS-CVLINFLLFLVP
TLVMMTVYSKIFLIAKQQAQNMEKMSkrASDSYKDRVAKRERKAAKTLGIAVAAFLLSWLPYLIDSIIDA
FLGFITPSYVYEILVWIVYYNSAMNPLIYAFFYPWFRNAIKLIVTGKILKQNSSTTNLFS-
>18:Q923Y5 Trace amine-associated receptor 6 OS=Rattus norvegicus OX=10116 GN=Taar6 PE=3 SV=1 2 301 6e-100 1 99.4% 42.6% 1:340 1:342
MGSNSSPPAVLQLCYENVNGSCVKTPYSPGPRVLLYAVFGFGAVLAVFGNLLVMISILHFKQLHSPTNFL
IASLACADFWVGVSVMPFSMVRSIESCWYFGRSFCTFHTCCDVAFCYSSLFHLSFISIDRYIAVTDPLVY
PTKFTVSVSGICISISWILPLAYSGAVFYTGVYADGLEEVSDAVNCVGGCQVVVNQNWVLIDF-LSFLIP
TLVMIILYGNIFLVARQQAKKigNKAESSSESYKARVARRERKAAKTLGITVVAFMISWLPYSIDSLVDA
FMGFITPAYIYEICVWCAYYNSAMNPLIYALFYPWFKKAIKVIMSGQVFKNSSATMNLFS-
>19:Q5QD05 Trace amine-associated receptor 8c OS=Mus musculus OX=10090 GN=Taar8c PE=2 SV=1 2 301 1e-99 1 96.2% 41.9% 12:340 11:343
-----------QLCYENTNGSCIKTPYSPGPRVILYMVYGFGAVLAVCGNLLVVISVLHFKQLHSPANFL
IASLASADFLVGISVMPFSMVRSIESCWYFGDAFCSLHSCCDVAFCYSSALHLCFISVDRYIAVTDPLVY
PTKFTVSVSGICISISWILPLVYSSAVFYTGISAKGIESLVSALNCVGGCQVVVNQDWVLISFLL-FFIP
TVVMIILYSKIFLVAKQQAVKIETsgESSSESHKARVAKRERKAAKTLGVTVVAFMVSWLPYTIDALVDA
FMGFITPAYVYEICCWSAYYNSAMNPLIYAFFYPWFRKAIKLILSGKILKGHSSTTNLFS-
>20:Q96RI9 Trace amine-associated receptor 9 OS=Homo sapiens OX=9606 GN=TAAR9 PE=2 SV=1 2 300 2e-99 1 99.4% 40.9% 1:340 1:342
MVNNFSQAEAVELCYKNVNESCIKTPYSPGPRSILYAVLGFGAVLAAFGNLLVMIAILHFKQLHTPTNFL
IASLACADFLVGVTVMPFSTVRSVESCWYFGDSYCKFHTCFDTSFCFASLFHLCCISVDRYIAVTDPLTY
PTKFTVSVSGICIVLSWFFSVTYSFSIFYTGANEEGIEELVVALTCVGGCQAPLNQNWVLLCFLL-FFIP
NVAMVFIYSKIFLVAKHQARKIESTASQAQSSSEsrVAKRERKAAKTLGIAMAAFLVSWLPYLVDAVIDA
YMNFITPPYVYEILVWCVYYNSAMNPLIYAFFYQWFGKAIKLIVSGKVLRTDSSTTNLFS-
>21:Q5QD13 Trace amine-associated receptor 6 OS=Mus musculus OX=10090 GN=Taar6 PE=2 SV=1 2 299 6e-99 1 99.4% 41.8% 1:340 1:342
MGSNSSPPTVLQLCYENVTGSCVKTPYSPGSRVILYAVFGFGAVLAVFGNLMVMISILHFKQLHSPTNFL
IASLACADFGVGISVMPFSMVRSIESCWYFGRSFCTFHTCCDVAFCYSSLFHLSFISIDRYIAVTDPLVY
PTKFTVSVSGICIGVSWILPLVYSGAVFYTGVYDDGLEELSSALNCVGGCQVVVNQNWVLIDF-LSFLIP
TLVMIILYGNIFLVARQQAKKIENIGSksSESYKARVARRERKAAKTLGITVVAFMISWLPYSIDSLVDA
FMGFITPAYIYEICVWCAYYNSAMNPLIYALFYPWFKKAIKVIMSGQVFKNSSATMNLFS-
>22:Q5W8W0 Trace amine-associated receptor 6 OS=Pan troglodytes OX=9598 GN=TAAR6 PE=3 SV=1 2 298 9e-99 1 99.4% 42.6% 1:340 1:342
MSSNSSLLVAVQLCYPNVNGSCVETLYSPGSRVILYIVFGFGAVLAVFGNLLVMISILHFKQLHSPTNFL
VASLACADFLVGVTVMPFSMVRTVESCWYFGRSFCTFHTCCDVAFCYSSLFHLCFISIDRYIAVTDPLVY
PTKFTVSVSGICISVSWILPLMYSGAVFYTGVYDDGLEELSDALNCIGGCQTVVNQNWVLIDC-LSFFIP
TFIMIILYGNIFLVARRQAKKIENTGSksSESYKARVARRERKAAKTLGVTVVAFMISWLPYSIDSLIDA
FMGFITPAYIYEICCWCAYYNSAMNPLIYALFYPWFRKAIKVIVTGQVLKNSSATMNLFS-
>23:Q5QD06 Trace amine-associated receptor 8b OS=Mus musculus OX=10090 GN=Taar8b PE=2 SV=1 2 298 1e-98 1 96.2% 42.2% 12:340 11:343
-----------QLCYENTNGSCIKTPYSPGPRVILYMVFGFGAVLAVCGNLLVVISVLHFKQLHSPANFL
IASLASADFLVGISVMPFSMVRSIESCWYFGDAFCSLHSCCDVAFCYSSALHLCFISVDRYIAVTDPLVY
PTKFTVSVSGICISISWILPLVYSSAVFYTGISAKGIESLVSALNCVGGCQIVVNQDWVLIDFLL-FFIP
TLVMIILYSKIFLVAKQQAVKIETsgESSSESHKARVAKRERKAAKTLGVTVVAFMVSWLPYTIDSLVDA
FVGFITPAYVYEICCWSAYYNSAMNPLIYAFFYPWFRKAIKLILSGEILKSHSSTMSLFS-
>24:Q923Y3 Trace amine-associated receptor 8b OS=Rattus norvegicus OX=10116 GN=Taar8b PE=3 SV=1 2 296 4e-98 1 96.2% 42.6% 12:340 11:343
-----------QLCYENVNASCIKTPYSPGLRVLLYMVFGFGAVLAVCGNLLVVISVLHFKQLHSPANFL
IASLASADFLVGISVMPFSMVRSIESCWYFGDTFCSLHSCCDAAFCYSSLFHLCFISVDRYIAVTEPLVY
PTKFTMSVSGICISISWILPLVYSSAVFYTGISATGIENLVSALNCVGGCQVAINQDWVLISFLL-FFIP
TLVMIILYSKIFLVAKQQAVKIETSISGSkeSHKARVAKRERKAAKTLGVTVMAFMVSWLPYTIDTLIDA
FMGFITPAYVYEICGWIAYYNSAMNPLIYAFFYPWFRKAIKLILSGKILKGHSSTTSLFS-
>25:Q96RI8 Trace amine-associated receptor 6 OS=Homo sapiens OX=9606 GN=TAAR6 PE=2 SV=1 2 294 2e-97 1 99.4% 42.6% 1:340 1:342
MSSNSSLLVAVQLCYANVNGSCVKIPFSPGSRVILYIVFGFGAVLAVFGNLLVMISILHFKQLHSPTNFL
VASLACADFLVGVTVMPFSMVRTVESCWYFGRSFCTFHTCCDVAFCYSSLFHLCFISIDRYIAVTDPLVY
PTKFTVSVSGICISVSWILPLMYSGAVFYTGVYDDGLEELSDALNCIGGCQTVVNQNWVLTDF-LSFFIP
TFIMIILYGNIFLVARRQAKKIENTGSksSESYKARVARRERKAAKTLGVTVVAFMISWLPYSIDSLIDA
FMGFITPACIYEICCWCAYYNSAMNPLIYALFYPWFRKAIKVIVTGQVLKNSSATMNLFS-
>26:Q923X9 Trace amine-associated receptor 8a OS=Rattus norvegicus OX=10116 GN=Taar8a PE=3 SV=2 2 294 5e-97 1 96.8% 42.3% 10:340 9:343
---------PLQLCYENVNASCIKTPYSPGLRVLLYMVFGFGAVLAVCGNLLVVISVLHFKQLHSPANFL
IASLASADFLVGISVMPFSMVRSIESCWYFGDTFCSLHSCCDAAFCYSSLFHLCFISVDRYIAVTDPLVY
PTKFTVSVSGICISISWILPLVYSSAVFYTGISATGIENLVSALNCVGGCQIVVNQDWVLIDFLL-FLIP
TLVMIILYSKIFLVAKQQAVKIETSISGSkeSHKARVAKRERKAAKTLGVTVVAFMVSWLPYTIDTLIDA
FMGFITPAYVYEICCWSAYYNSAMNPLIYAFFYPWFRKAIKLILSGEILKSHSSTMSLFS-
>27:Q923Y0 Trace amine-associated receptor 8c OS=Rattus norvegicus OX=10116 GN=Taar8c PE=3 SV=1 2 293 7e-97 1 96.2% 42.2% 12:340 11:343
-----------QLCYENVNASCIKTPYSPGLRVLLYMVFGFGAVLAVCGNLLVVISVLHFKQLHSPANFL
IASLASADFLVGISVMPFSMVRSIESCWYFGDTFCSLHSCCDVAFCYSSALHLCFISVDRYIAVTDPLVY
PTKFTVSVSGICISISWILPLVYSSAVFYTGISAMGIENLVSALNCVGGCQVVVNQDWVLISFLL-FFIP
TLVMIILYSKIFLVAKQQAVKIETsgESSLESHKARVAKRERKAAKTLGVTVLAFIVSWLPYTIDTLIDA
FMGFITPAYVYEFCCWSAYYNSAMNPLIYAFFYPWFRKAMKLILSGKILKGHSSTTSLFS-
>28:Q5QD25 Trace amine-associated receptor 2 OS=Rattus norvegicus OX=10116 GN=Taar2 PE=2 SV=1 2 293 7e-97 1 94.4% 47.7% 14:340 13:334
-------------CSEYGNGSCPENERSLGVRAAMYSLMAGAIFITIFGNLVMIISISYFKQLHTPTNLL
ILSMAVTDFLLGFTIMPYSMVRSVENCWYFGLTFCKIHYSFDLMLSITSIFHLCSVAIDRFYAICHPLHY
CTKMTIPVVKRLLLVCWSVPGAFAFGVVFSEAYADGIEGYDILVACSSSCPVMFNKLWGTTLFVAGFFTP
SSMMVGIYGKIFAVSKKHARVIDNLPENQN-----NQMRKDKKAAKTLGIVMGVFLLCWFPCFFTILLDP
FLNFSTPAILFDALTWFGYFNSTCNPLIYGFFYPWFRRALRYILLGKIFSSHFHNTNLFT-
>29:P43141 Beta-4C adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB4C PE=2 SV=1 2 296 1e-96 1 93.8% 34.8% 16:340 5:340
---------------PAGNGSVPnwAAVLSRQWAVGAALSITILVIVAGNLLVIVAIAKTPRLQTMTNVF
VTSLACADLVMGLLVVPPGATILLSGHWPYGTVVCELWTSLDVLCVTASIETLCAIAVDRYLAITAPLQY
EALVTKGRAWAVVCMVWAISAFISFLPIMNHWWRDGADeaVRCYDDPRCCDFVTNMTYAIVSSTVSFYVP
LLVMIFVYVRVFAVATRHVQLIGksRGGRWRRPSRLLAIKEHKALKTLGIIMGTFTLCWLPFFVANIIKV
FCRPLVPDQLFLFLNWLGYVNSAFNPIIY-CRSPDFRSAFRKLLCC----PRRADRRLHA-
>30:Q5QD17 Trace amine-associated receptor 2 OS=Mus musculus OX=10090 GN=Taar2 PE=2 SV=1 2 291 4e-96 1 94.4% 47.7% 14:340 13:334
-------------CSEYGNGSCPENERSLGVRAAMYSLMACAIFITIFGNLAMIISISYFKQLHTPTNLL
ILSMAVTDFLLGFTIMPYSMVRSVENCWYFGLTFCKIHYSFDLMLSITSIFHLCSVAVDRFYAICHPLHY
CTKMTIPVVRRLLLVCWSVPGAFAFGVVFSEAYADGIEGYDILVACSSSCPVMFNKLWGTTLFVAGFFTP
SSMMVGIYGKIFAVSKKHARVIDNLPENQN-----NQMRKDKKAAKTLGIVMGVFLLCWFPCFFTILLDP
FLNFSTPAVLFDALTWFGYFNSTCNPLIYGFFYPWFRRALKYILLGKIFSSHFHNTNLFT-
>31:P07700 Beta-1 adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB1 PE=1 SV=1 2 296 5e-96 1 88.3% 32.4% 35:340 44:369
----------------------------------MSLLMALVVLLIVAGNVLVIAAIGRTQRLQTLTNLF
ITSLACADLVMGLLVVPFGATLVVRGTWLWGSFLCECWTSLDVLCVTASIETLCVIAIDRYLAITSPFRY
QSLMTRARAKVIICTVWAISALVSFLPIMMHWWRDEDPQALKCYQDPGCCDFVTNRAYAIASSIISFYIP
LLIMIFVYLRVYREAKEQIRKIDRCEGrsKRKTSRVMAMREHKALKTLGIIMGVFTLCWLPFFLVNIVNV
FNRDLVPDWLFVFFNWLGYANSAFNPIIY-CRSPDFRKAFKRLLCF----PRKADRRLHA-
>32:Q5QD07 Trace amine-associated receptor 8a OS=Mus musculus OX=10090 GN=Taar8a PE=2 SV=1 2 291 5e-96 1 96.2% 41.0% 12:340 11:343
-----------QLCYENTNGSCIKTPYSPGPRVILYMVYGFGAVLAVCGNLLVVISVLHFKQLHSPANFL
IASLASADFLVGISVMPFSMVRSIESCWYFGDAFCSLHSCCDVAFCYSSVLHLCFISVDRYIAVTDPLVY
PTKFTVSVSGICISISWILPLVYSSAVFYTGISAKGIESLVSALNCVGGCQIVINQDFVLISFLL-FFIP
TLVMIILYSKIFLVAKQQAVKIETsgESSSESHKARVAKRERKAAKTLGVTVVAFMVSWLPYTIDALVDA
FMGFITPAYVYEICCWGTYYNSAMNPLIYAFFFPWFKKAIKLILSGEILKGHSSTANLFS-
>33:Q9TST5 Beta-2 adrenergic receptor OS=Felis catus OX=9685 GN=ADRB2 PE=3 SV=1 2 292 3e-95 1 90.9% 31.8% 17:327 16:343
----------------GSHAPDQDGTQERNDAWVVgiVMSLIVLAIVFGNVLVITAIARFERLQTVTNYF
ITSLACADLVMGLAVVPFGASHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKY
QSLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHQEAINCYAKETCCDFFTNQAYAIASSIVSFYLP
LVVMVFVYSRVFQVAQRQLQKiqDGRSGHGHRRASKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHV
IQDNLIPKEVYILLNWVGYVNSAFNPLIY-CRSPDFRIAFQELLCLR--------------
>34:P18841 Alpha-1B adrenergic receptor OS=Mesocricetus auratus OX=10036 GN=ADRA1B PE=1 SV=1 2 294 7e-95 1 86.5% 34.0% 28:330 41:369
---------------------------DVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYF
IVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQY
PTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDD--------KECGVTEEPFYALFSSLGSFYIP
LAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELtfSREKKAAKTLGIVVGMFILCWLPFFIAllGSL
FSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRS-----------
>35:P15823 Alpha-1B adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adra1b PE=1 SV=2 2 293 1e-94 1 85.9% 34.2% 28:328 41:367
---------------------------DVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYF
IVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQY
PTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDD--------KECGVTEEPFYALFSSLGSFYIP
LAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELtfSREKKAAKTLGIVVGMFILCWLPFFIAllGSL
FSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQC-------------
>36:P54833 Beta-2 adrenergic receptor OS=Canis lupus familiaris OX=9615 GN=ADRB2 PE=2 SV=1 2 289 5e-94 1 94.7% 31.2% 4:327 1:343
---MGQPANRSVFlaPNGSHAPDQGDSQERSEAWVviVMSLIVLAIVFGNVLVITAIARFERLQTVTNYF
ITSLACADLVMGLAVVPFGASHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKY
QSLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHQEAINCYAKETCCDFFTNQAYAIASSIVSFYLP
LVVMVFVYSRVFQVAQRQLQKiqDGRSGHGHRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHV
IQDNLIPKEVYILLNWVGYVNSAFNPLIY-CRSPDFRIAFQELLCLR--------------
>37:P04274 Beta-2 adrenergic receptor OS=Mesocricetus auratus OX=10036 GN=ADRB2 PE=1 SV=1 2 288 6e-94 1 85.6% 32.1% 35:327 36:343
----------------------------------MAILMSVIVLAIVFGNVLVITAIAKFERLQTVTNYF
ITSLACADLVMGLAVVPFGASHILMKMWNFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYIAITSPFKY
QSLLTKNKARMVILMVWIVSGLTSFLPIQMHWYRATHQKAIDCYHKETCCDFFTNQAYAIASSIVSFYVP
LVVMVFVYSRVFQVAKRQLQKiqDGRSGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHV
IQDNLIPKEVYILLNWLGYVNSAFNPLIY-CRSPDFRIAFQELLCLR--------------
>38:P35368 Alpha-1B adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRA1B PE=1 SV=3 2 291 1e-93 1 93.8% 32.9% 1:328 5:367
LDTGHNTSAPAHWGekNANFTGPNQTSSNStaISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYF
IVNLAMADLLLSFTVLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQY
PTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDD--------KECGVTEEPFYALFSSLGSFYIP
LAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELtfSREKKAAKTLGIVVGMFILCWLPFFIAllGSL
FSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQC-------------
>39:Q5QD24 Trace amine-associated receptor 3 OS=Rattus norvegicus OX=10116 GN=Taar3 PE=3 SV=1 2 285 1e-93 1 99.1% 45.1% 1:339 1:338
MDLIYIPEDLSS-CPKFGNKSCPPTNRSFRVRLIMYLLMTGAMVITIFGNLVIIISISHFKQLHSPTNFL
ILSMATTDFLLGFVIMPYSMVRSVESCWYFGDSFCKFHASFDMMLSLTSIFHLCSIAIDRFYAVCAPLHY
TTTMTASMIKRLLFFCWAAPALFSFGLVLSEANVSGMQSYEILIACFNFCALTFNKFWGTILFTTCFFTP
GSIMVGIYGKIFIVSRRHARALGNMPENTKGAGRNLSKKKDRKAAKTLGIVMGVFLACWLPCFLAVLIDP
YLDYSTPIIVLDLLVWLGYFNSTCNPLIHGFFYPWFRKALEHIVSGKIFRSNSDTANLF--
>40:Q8HZ64 Trace amine-associated receptor 1 OS=Macaca mulatta OX=9544 GN=TAAR1 PE=3 SV=1 2 284 3e-93 1 96.2% 45.7% 13:340 3:334
------------FCHNIINISCVKNNWSNDVRASLYSLMALIILTTLVGNLIVIVSISHFKQLHTPTNWL
IHSMATVDFLLGCLVMPYSMVRSAEHCWYFGEVFCKIHTSTDIMLSSASIFHLSFISIDRYYAVCDPLRY
KAKINILVVCVMIFISWSVPAVFAFGMIFLELNFKGAEeyYKHVHCRGGCSVFFSKISGVLAFMTSFYIP
GSIMLCIYYRIYLIAKEQARSINDANQKLqeMKNGISQSKERKAVKTLGIVMGVFLICWCPFFVCTVIDP
FLHYTIPPTLNDVLIWFGYLNSTFNPMVYAFFYPWFRKALKMILFGKIFQKDSSRCKLFL-
>41:Q4KWL2 Beta-2 adrenergic receptor OS=Tscherskia triton OX=329627 GN=ADRB2 PE=2 SV=1 2 287 3e-93 1 85.6% 32.4% 35:327 36:343
----------------------------------MAILMSVIVLAIVFGNVLVITAIAKFERLQTVTNYF
ITSLACADLVMGLAVVPFGASHILMKMWNFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYIAITSPFKY
QSLLTKNKARMVILMVWIVSGLTSFLPIQMHWYRATHEKAITCYRNETCCDFFTNQAYAIASSIVSFYVP
LVVMVFVYSRVFQVAKRQLQKiqDGRSGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHV
IQENLIPKEVYILLNWLGYVNSAFNPLIY-CRSPDFRIAFQELLCLR--------------
>42:P18762 Beta-2 adrenergic receptor OS=Mus musculus OX=10090 GN=Adrb2 PE=1 SV=2 2 287 3e-93 1 85.6% 32.4% 35:327 36:343
----------------------------------MAILMSVIVLAIVFGNVLVITAIAKFERLQTVTNYF
IISLACADLVMGLAVVPFGASHILMKMWNFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYVAITSPFKY
QSLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHKKAIDCYTEETCCDFFTNQAYAIASSIVSFYVP
LVVMVFVYSRVFQVAKRQLQKiqDGRSGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHV
IRDNLIPKEVYILLNWLGYVNSAFNPLIY-CRSPDFRIAFQELLCLR--------------
>43:P97718 Alpha-1A adrenergic receptor OS=Mus musculus OX=10090 GN=Adra1a PE=1 SV=3 2 288 3e-93 1 93.0% 30.5% 11:335 5:352
----------SENASEGSNCTHPPAQVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYY
IVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRY
PTIVTQRRGVRALLCVWALSLVISIGPLFGWRQQAPEDETI--------CQINEEPGYVLFSALGSFYVP
LTIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVtfSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGS
fpNFKPPETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSS------
>44:Q5QD16 Trace amine-associated receptor 3 OS=Mus musculus OX=10090 GN=Taar3 PE=2 SV=1 2 284 4e-93 1 99.1% 46.3% 1:339 1:339
MDLIYIPEDLSS-CPKFGNKSCPPTNRSFRVRMIMYLFMTGAMVITIFGNLVIIISISHFKQLHSPTNFL
ILSMATTDFLLGFVIMPYSMVRSVESCWYFGDSFCKFHASFDMMLSLTSIFHLCSIAIDRFYAVCDPLHY
TTTMTVSMIKRLLAFCWAAPALFSFGLVLSEANVSGMQSYEILVACFNFCALTFNKFWGTILFTTCFFTP
GSIMVGIYGKIFIVSRRHARALSDMPANTKGAVGKNLSKKkrKAAKTLGIVMGVFLACWLPCFLAVLIDP
YLDYSTPIIVLDLLVWLGYFNSTCNPLIHGFFYPWFRKALQFIVSGKIFRSNSDTANLF--
>45:Q28509 Beta-2 adrenergic receptor OS=Macaca mulatta OX=9544 GN=ADRB2 PE=2 SV=1 2 286 6e-93 1 85.6% 31.7% 35:327 36:343
----------------------------------MGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYF
ITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKY
QSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYAKETCCDFFTNQAYAIASSIVSFYVP
LVIMVFVYSRVFQEAKRQLQKIDKSEGrhGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHV
IQDNLIPKEVYILLNWVGYVNSGFNPLIY-CRSPDFRIAFQELLCLR--------------
>46:Q28997 Beta-2 adrenergic receptor OS=Sus scrofa OX=9823 GN=ADRB2 PE=2 SV=2 2 286 7e-93 1 85.6% 31.4% 35:327 36:343
----------------------------------MAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYF
ITSLACADLVMGLAVVPFGASHILMKMWTFGSFWCEFWISIDVLCVTASIETLCVIAVDRYLAITSPFKY
QCLLTKNKARVVILMVWVVSGLISFLPIKMHWYQATHREALNCYAEEACCDFFTNQPYAIASSIVSFYLP
LVVMVFVYSRVFQVARRQLQKiqDGRSGPGHRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHG
IHDNLIPKEVYILLNWVGYVNSAFNPLIY-CRSPDFRMAFQELLCLH--------------
>47:Q9P1P5 Trace amine-associated receptor 2 OS=Homo sapiens OX=9606 GN=TAAR2 PE=2 SV=2 2 283 7e-93 1 97.7% 45.9% 1:338 1:344
MAVSSEQHELSHfcSEYGNRSCPENERSLGVRVAMYSFMAGSIFITIFGNLAMIISISYFKQLHTPTNFL
ILSMAITDFLLGFTIMPYSMIRSVENCWYFGLTFCKIYYSFDLMLSITSIFHLCSVAIDRFYAICYPLLY
STKITIPVIKRLLLLCWSVPGAFAFGVVFSEAYADGIEGYDILVACSSSCPVMFNKLWGTTLFMAGFFTP
GSMMVGIYGKIFAVSRKHAHAINNLRENQN-----NQVKKDKKAAKTLGIVIGVFLLCWFPCFFTILLDP
FLNFSTPVVLFDALTWFGYFNSTCNPLIYGFFYPWFRRALKYILLGKIFSSCFHNTIL---
>48:Q8K4Z4 Beta-2 adrenergic receptor OS=Cavia porcellus OX=10141 GN=Adrb2 PE=3 SV=1 2 286 7e-93 1 85.6% 32.8% 35:327 36:343
----------------------------------MAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYF
ITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKY
QSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLP
LVVMVFVYSRVFQVAKKQLQKiqDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHV
IQDNLIPKEVYILLNWVGYVNSAFNPLIY-CRSPDFRIAFQELLCLR--------------
>49:P97717 Alpha-1B adrenergic receptor OS=Mus musculus OX=10090 GN=Adra1b PE=1 SV=2 2 289 8e-93 1 90.3% 32.6% 13:328 25:366
------------FTGPNQTSSNSTLPQLDVTRAISVGCLGAFILFAIVGNILVILSVACNRHLRTPTNYF
IVNLAIADLLLSFTDLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQY
PTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDD--------KECGVTEEPFYALFSSLGSFYIP
LAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELtfSREKKAAKTLGIVVGMFILCWLPFFIAllGSL
FSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQC-------------
>50:P10608 Beta-2 adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adrb2 PE=1 SV=1 2 285 1e-92 1 85.6% 32.4% 35:327 36:343
----------------------------------MAILMSVIVLAIVFGNVLVITAIAKFERLQTVTNYF
ITSLACADLVMGLAVVPFGASHILMKMWNFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYVAITSPFKY
QSLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRATHKQAIDCYAKETCCDFFTNQAYAIASSIVSFYVP
LVVMVFVYSRVFQVAKRQLQKiqDGRSGHGLRSSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHV
IRANLIPKEVYILLNWLGYVNSAFNPLIY-CRSPDFRIAFQELLCLR--------------
>51:P43140 Alpha-1A adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adra1a PE=2 SV=1 2 286 2e-92 1 93.0% 29.8% 11:335 5:352
----------SENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYY
IVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRY
PTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETI--------CQINEEPGYVLFSALGSFYVP
LAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVtfSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGS
fpDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSS------
>52:O14804 Trace amine-associated receptor 5 OS=Homo sapiens OX=9606 GN=TAAR5 PE=2 SV=2 2 282 2e-92 1 96.8% 42.7% 3:339 6:335
--IQGAEEHPAAFCY-QVNGSCPRTVHTLGIQLVIYLACAAGMLIIVLGNVFVAFAVSYFKALHTPTNFL
LLSLALADMFLGLLVLPLSTIRSVESCWFFGDFLCRLHTYLDTLFCLTSIFHLCFISIDRHCAICDPLLY
PSKFTVRVALRYILAGWGVPAAYTSLFLYTDVVETRLSQWLEEMPCVGSCQLLLNKFWGWLNFPL-FFVP
CLIMISLYVKIFVVATRQAQQITTLSKS-----LAGAAKHERKAAKTLGIAVGIYLLCWLPFTIDTMVDS
LLHFITPPLVFDIFIWFAYFNSACNPIIYVFSYQWFRKALKLTLSQKVFSPQTRTVDLY--
>53:Q923Y8 Trace amine-associated receptor 1 OS=Mus musculus OX=10090 GN=Taar1 PE=2 SV=1 2 281 2e-92 1 96.5% 44.1% 12:340 2:332
-----------HLCHAITNISHRNSDWSREVQASLYSLMSLIILATLVGNLIVIISISHFKQLHTPTNWL
LHSMAIVDFLLGCLIMPCSMVRTVERCWYFGEILCKVHTSTDIMLSSASIFHLAFISIDRYCAVCDPLRY
KAKINISTILVMILVSWSLPAVYAFGMIFLELNLKGVEeyRSQVSDLGGCSPFFSKVSGVLAFMTSFYIP
GSVMLFVYYRIYFIAKGQARSINRTnqVGLEGKSQAPQSKETKAAKTLGIMVGVFLVCWCPFFLCTVLDP
FLGYVIPPSLNDALYWFGYLNSALNPMVYAFFYPWFRRALKMVLLGKIFQKDSSRSKLFL-
>54:O02824 Alpha-1A adrenergic receptor OS=Oryctolagus cuniculus OX=9986 GN=ADRA1A PE=2 SV=1 2 286 2e-92 1 93.0% 30.2% 11:335 5:352
----------SGNASDSSNCTHPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYY
IVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIISLCVISIDRYIGVSYPLRY
PTIVTQRRGLRALLCVWAFSLVISVGPLFGWRQPAPDDETI--------CQINEEPGYVLFSALGSFYVP
LTIILAMYCRVYVVAKRESRGLKSGLKTDKSDSEQVtfSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGS
fpDFKPPETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLKIQCLRRKQSS------
>55:P07550 Beta-2 adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRB2 PE=1 SV=3 2 284 3e-92 1 85.6% 31.4% 35:327 36:343
----------------------------------MGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYF
ITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKY
QSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVP
LVIMVFVYSRVFQEAKRQLQKIDKSEGrhGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHV
IQDNLIRKEVYILLNWIGYVNSGFNPLIY-CRSPDFRIAFQELLCLR--------------
>56:Q5QD28 Trace amine-associated receptor 5 OS=Pan troglodytes OX=9598 GN=TAAR5 PE=3 SV=1 2 281 5e-92 1 96.8% 42.7% 3:339 6:335
--IQGAEEHPAAFCY-QVNGSCPRTVHTLGIQLVIYLACAAGMLIIVLGNLFVAFAVSYFKALHTPTNFL
LLSLALADMFLGLLVLPLSTIRSVESCWFFGDFLCRLHTYLDPLFCLTSIFHLCFISIDRHCAICDPLLY
PSKFTVRVALRYILAGWGVPAAYTSLFLYTDVVETRLSQWLEEMPCVGSCQLLLNKFWGWLNFPL-FFVP
CLIMISLYVKIFVVATRQAQQITTLSKN-----LAGAAKHDRKAAKTLGIAVGIYLLCWLPFTIDTMVDS
LLHFITPPLVFDIFIWFAYFNSACNPIIYVFSYQWFRKALKLTLSQKVFSPQTRTVDLY--
>57:Q96RJ0 Trace amine-associated receptor 1 OS=Homo sapiens OX=9606 GN=TAAR1 PE=2 SV=1 2 280 7e-92 1 96.2% 44.8% 13:340 4:335
------------FCHNIINISCVKNNWSNDVRASLYSLMVLIILTTLVGNLIVIVSISHFKQLHTPTNWL
IHSMATVDFLLGCLVMPYSMVRSAEHCWYFGEVFCKIHTSTDIMLSSASIFHLSFISIDRYYAVCDPLRY
KAKMNILVICVMIFISWSVPAVFAFGMIFLELNFKGAEeyYKHVHCRGGCSVFFSKISGVLTFMTSFYIP
GSIMLCVYYRIYLIAKEQARLISDANQKLqeMKNGISQSKERKAVKTLGIVMGVFLICWCPFFICTVMDP
FLHYIIPPTLNDVLIWFGYLNSTFNPMVYAFFYPWFRKALKMMLFGKIFQKDSSRCKLFL-
>58:Q923Y9 Trace amine-associated receptor 1 OS=Rattus norvegicus OX=10116 GN=Taar1 PE=2 SV=1 2 279 1e-91 1 96.5% 44.4% 12:340 2:332
-----------HLCHNSANISHTNSNWSRDVRASLYSLISLIILTTLVGNLIVIISISHFKQLHTPTNWL
LHSMAVVDFLLGCLVMPYSMVRTVEHCWYFGELFCKLHTSTDIMLSSASILHLAFISIDRYYAVCDPLRY
KAKINLAAIFVMILISWSLPAVFAFGMIFLELNLEGVEeyHNQVFCLRGCFPFFSKVSGVLAFMTSFYIP
GSVMLFVYYRIYFIAKGQARSINRAnqVGLEGESRAPQSKETKAAKTLGIMVGVFLLCWCPFFFCMVLDP
FLGYVIPPTLNDTLNWFGYLNSAFNPMVYAFFYPWFRRALKMVLFGKIFQKDSSRSKLFL-
>59:Q969N4 Trace amine-associated receptor 8 OS=Homo sapiens OX=9606 GN=TAAR8 PE=2 SV=1 2 279 2e-91 1 96.2% 40.4% 12:340 11:341
-----------QLCYEDVNGSCIETPYSPGSRVILYTAFSFGSLLAVFGNLLVMTSVLHFKQLHSPTNFL
IASLACADFLVGVTVMLFSMVRTVESCWYFGAKFCTLHSCCDVAFCYSSVLHLCFICIDRYIVVTDPLVY
ATKFTVSVSGICISVSWILPLTYSGAVFYTGVNDDGLEELVSALNCVGGCQIIVSQGWVLIDFLL-FFIP
TLVMIILYSKIFLIAKQQAIKisSKVESSSESYKIRVAKRERKAAKTLGVTVLAFVISWLPYTVDILIDA
FMGFLTPAYIYEICCWSAYYNSAMNPLIYALFYPWFRKAIKLILSGDVLKASSSTISLFL-
>60:Q5QD29 Trace amine-associated receptor 1 OS=Pan troglodytes OX=9598 GN=TAAR1 PE=3 SV=1 2 278 5e-91 1 96.2% 44.5% 13:340 4:335
------------FCHNIINISCVKNNWSNDVRASLYSLMVLIILTTLVGNLIVIVSISHFKELHTPTNWL
IHSMATVDFLPGCLVMPYSMVRSAEHCWYFGEVFCKIHTSTDIMLSSASIFHLSFISIDRYYAVCDPLRY
KAKINILVICVMIFISWSVPAVFAFGMIFLELNFKGAEeyYKHVHCRGGCSVFFSKISGVLTFMTSFYIP
GSIMLCVYYRIYLIAKEQARLINDANQKLqeMKNGISQSKERKAVKTLGIVMGVFLICWCPFFICTVMDP
FLHYIIPPTLNDVLIWFGYLNSTFNPMVYAFFYPWFRKALKMMLFGKIFQKDSSRCKLFL-
>61:P53454 D(5)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=dl PE=3 SV=1 2 282 7e-91 1 89.1% 31.1% 26:334 33:358
-------------------------VGGVSVRALTGCVLCALIVSTLLGNTLVCAAVIKFRHLRsvTNAF
VVSLAVSDLFVAVLVMPWRAVSEVAGVWLFGR-FCDTWVAFDIMCSTASILNLCVISMDRYWAISNPFRY
ERRMTRRFAFLMIAVAWTLSVLISFIPVQLNWHRA---DNNSSAHEQGDCNASLNRTYAISSSLISFYIP
VLIMVGTYTRIFRIAQTQIRRISSLErtHDESALKTSFKRETKVLKTLSVIMGVFVFCWLPFFVLNCVVP
FCDvcVSDTTFNIFVWFGWANSSLNPVIYAF-NADFRKAFTTILGCSKFCSSSA-------
>62:Q28927 Beta-1 adrenergic receptor OS=Ovis aries OX=9940 GN=ADRB1 PE=2 SV=2 2 282 9e-91 1 88.6% 35.0% 24:326 48:380
-----------------------RGTPLLSQQWTVglLMAFIVLLIVAGNVLVIVAIAKTPRLQTLTNLF
IMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRY
QSLLTRARARALVCTVWAISALVSFLPIFMQWWGDKDAKASRCYNDPECCDFIINEGYAITSSVVSFYVP
LCIMAFVYLRVFREAQKQVKKIDSCERrnKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKA
FHRDLVPDRLFVFFNWLGYANSAFNPIIY-CRSPDFRKAFQRLLCC---------------
>63:P35348 Alpha-1A adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRA1A PE=1 SV=2 2 282 9e-91 1 93.0% 30.5% 11:335 5:352
----------SGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYY
IVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRY
PTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETI--------CQINEEPGYVLFSALGSFYLP
LAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVtfSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGS
fpDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSS------
>64:Q9WU25 Alpha-1A adrenergic receptor OS=Cavia porcellus OX=10141 GN=ADRA1A PE=2 SV=2 2 282 1e-90 1 93.0% 29.5% 11:335 5:352
----------SGNASDSSNCTQPPAPVNIPKAILLGVILGVLILFGVPGNILVILSVACHRHLHSVTHYY
IVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMSLCIISIDRYIGVSYPLRY
PTIVTQRRGLRALLCLWALSLVISIGPLFGWRQPAPQDETI--------CQINEDPSYVLFSALGSFYVP
LAIILVMYCRVYVVAKRESRGLTSGLKTDKSDSEQVtfSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGS
fpDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLKIQCLRRKQSS------
>65:O70528 5-hydroxytryptamine receptor 4 OS=Cavia porcellus OX=10141 GN=HTR4 PE=2 SV=1 2 279 1e-90 1 90.6% 35.8% 17:326 5:329
----------------DANVSSKEGFGSVE-KVVLLTFLSAVILMAILGNLLVMVAVCRDRQLRKitNYF
IVSLAFADLLVSVLVMPFGAIELVQDIWVYGEMFCLVRTSLDVLLTTASIFHLCCISLDRYYAIcqPLVY
RNKMTPLRIALMLGGCWVIPMFISFLPIMQGWNNIGIVDLIEknSNSTYCVFMVNKPYAITCSVVAFYIP
FLLMVLAYYRIYVTAKEHARQIQVLQrqPADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDP
FIDYTVPGQLWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCC---------------
>66:Q28044 Beta-2 adrenergic receptor OS=Bos taurus OX=9913 GN=ADRB2 PE=2 SV=2 2 279 2e-90 1 92.1% 31.4% 10:327 14:343
---------PNASHAPDQNVTLERDEAWV---VGMGILMSLIVLAIVFGNVLVITAIAKFERLQTVTNYF
ITSLACADLVMGLAVVPFGACHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYLAITSPFKY
QCLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRASHKEAINCYAKETCCDFFTNQPYAIASSIVSFYLP
LVVMVFVYSRVFQVAKRQLQKIDKSEGRFhqRRTSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHV
IKDNLIRKEIYILLNWLGYINSAFNPLIY-CRSPDFRIAFQELLCLR--------------
>67:P18130 Alpha-1A adrenergic receptor OS=Bos taurus OX=9913 GN=ADRA1A PE=2 SV=1 2 281 2e-90 1 93.0% 29.8% 11:335 5:352
----------SGNASDSSNCTHPPPPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYY
IVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNVWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRY
PTIVTQKRGLMALLCVWALSLVISIGPLFGWRQPAPEDETI--------CQINEEPGYVLFSALGSFYVP
LTIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVtfSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGS
fpDFRPSETVFKIAFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRKQSS------
>68:P25100 Alpha-1D adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRA1D PE=1 SV=2 2 284 3e-90 1 91.2% 33.9% 2:320 64:413
-DNRSSAGEpsAGAGGDVNGTAAVGGLVVSAQGvvGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYF
IVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKY
PAIMTERKAAAILALLWVVALVVSVGPLLGWKEPVPPDERF--------CGITEEAGYAVFSSVCSFYLP
MAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEvkFSREKKAAKTLAIVVGVFVLCWFPFfvLPLGSL
FPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAF---------------------
>69:Q9TT96 Beta-1 adrenergic receptor OS=Bos taurus OX=9913 GN=ADRB1 PE=3 SV=2 2 280 5e-90 1 89.4% 34.0% 21:326 45:380
--------------------SASEGPPLPSQQWtmGLLMAFIVLLIVVGNVLVLVAIAKTPRLQTLTNLF
IMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRY
QSLLTRARARALVCTVWAISALVSFLPIFMQWWGDKDAKASRCYNDPECCDFIINEGYAITSSVVSFYVP
LCIMAFVYLRVFREAQKQVKKIDSCERrnKRRPPRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKA
FHRDLVPDRLFVFFNWLGYANSAFNPIIY-CRSPDFRKAFQRLLCC---------------
>70:P97288 5-hydroxytryptamine receptor 4 OS=Mus musculus OX=10090 GN=Htr4 PE=1 SV=3 2 277 6e-90 1 90.6% 35.2% 17:326 5:329
----------------DANVSSNEGFRSVE-KVVLLTFLAVVILMAILGNLLVMVAVCRDRQLRKitNYF
IVSLAFADLLVSVLVMPFGAIELVQDIWAYGEMFCLVRTSLDVLLTTASIFHLCCISLDRYYAIcqPLVY
RNKMTPLRIALMLGGCWVLPMFISFLPIMQGWNNIGIVDVIEknSNSTWCVFMVNKPYAITCSVVAFYIP
FLLMVLAYYRIYVTAKEHAQQIQMLQrqPADQHSTHRMRTETKAAKTLCVIMGCFCFCWAPFFVTNIVDP
FIDYTVPEQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCC---------------
>71:P79148 Beta-1 adrenergic receptor OS=Canis lupus familiaris OX=9615 GN=ADRB1 PE=3 SV=1 2 280 7e-90 1 92.1% 33.0% 21:335 45:399
--------------------PTSEGPAPLSQQWtiGLLMALIVLLIVAGNVLVIAAIAKTPRLQTLTNLF
IMSLASADLVMGLLVVPFGATIVMRGRWEYGSFLCELWTSVDVLCVTASIETLCVIALDRYLAITAPFRY
QSLLTRARARALVCTVWAISALVSFLPILMHWWRAGGDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVP
LCIMAFVYLRVFREAQKQVKKIDSCERrgRRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKA
FHRDLVPDRLFVFFNWLGYANSAFNPIIY-CRSPDFRRAFQRLLCCARRAARGSH------
>72:Q5QD23 Trace amine-associated receptor 5 OS=Rattus norvegicus OX=10116 GN=Taar5 PE=3 SV=1 2 275 9e-90 1 96.8% 42.4% 3:339 6:335
--LPGSGEQPAAFCY-QVNGSCPRTVHPLAIRVLIYLACAVGMLITVLGNLFVVFAVSYFKVLHTPTNFL
LLSLALADMLLGLLVLPLSTVRSVESCWFFGDFLCRLHTYLDTLFCLTSIFHLCFISIDRHCAICDPLLY
PSKFTVRIALRYIAAGWGIPAAYTAFFLYTDVVERALSQWLEEMPCVGSCQLLFNKFWGWL-NFPAFFIP
CLIMISLYLKIFVVATRQAQQIRTLSQS-----LSGAVKRERKAAKTLGIAVGIYLVCWLPFTVDTLVDS
LLNFVTPPLVFDIFIWFAYFNSACNPIIYVFSYRWFRKALKLLLSREILSPRTQTADLF--
>73:Q5QD14 Trace amine-associated receptor 5 OS=Mus musculus OX=10090 GN=Taar5 PE=2 SV=1 2 275 1e-89 1 96.8% 42.7% 3:339 6:335
--LPGSGEQPTAFCY-QVNGSCPRTVHPLAIQVVIYLACAVGVLITVLGNLFVVFAVSYFKVLHTPTNFL
LLSLALADMLLGLLVLPLSTVRSVESCWFFGDFLCRLHTYLDTLFCLTSIFHLCFISIDRHCAICDPLLY
PSKFTVRTALRYIVAGWGIPAAYTAFFLYTDVVERALSQWLEEMPCVGSCQLLFNKFWGWL-NFPAFFVP
CLIMISLYLKIFVVATRQAQQIRTLSQS-----LAGAVKRERKAAKTLGIAVGIYLVCWLPFTVDTLVDS
LLNFITPPLVFDIFIWFAYFNSACNPIIYVFSYRWFRKALKLLLSREIFSPRTPTVDLY--
>74:Q91175 Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1 2 279 1e-89 1 94.7% 30.8% 10:340 3:357
---------PSSVTLNCSNCSHVLAPELNTVKAVVlmVLGIFILFGVIGNILVILSVVCHRHLQTVTYYF
IVNLAVADLLLSSTVLPFSAIFEILDRWVFGRVFCNIWAAVDVLCCTASIMSLCVISVDRYIGVSYPLRY
PAIMTKRRALLAVMLLWVLSVIISIGPLFGWKEPAPEDETV--------CKITEEPGYAIFSAVGSFYLP
LAIILAMYCRVYVVAQKESRGLKEGQKIEKSDSEQvkFSREKKAAKTLGIVVGCFVLCWLPFFLVLPIGs
fPAYRPSDTVFKITFWLGYFNSCINPIIYLCSNQEFKKAFQSLLGVHCLrpRAHHHHLSV-
>75:O42574 Beta-1 adrenergic receptor OS=Xenopus laevis OX=8355 GN=adrb1 PE=2 SV=1 2 274 6e-89 1 88.3% 33.3% 35:340 38:351
----------------------------------MTMFMAAIILLIVMGNIMVIVAIGRNQRLQTLTNVF
ITSLACADLIMGLFVVPLGATLVVSGRWLYGSIFCEFWTSVDVLCVTASIETLCVISIDRYIAITSPFRY
QSLLTKGRAKGIVCSVWGISALVSfpIMMHWWRDTGDPLAMKCYEDPGCCDFVTNRAYAIASSIISFYFP
LIIMIFVYIRVFKEAQKQMKKIDKCEGRFSHSHVLSHGRseQKALKTLGIIMGTFTLCWLPFFLANVVNV
FYRNLIPDKLFLFLNWLGYANSAFNPIIY-CRSPDFRKAFKRLLCC----PKKADRHLHT-
>76:P53452 D(1)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=d14 PE=3 SV=1 2 277 6e-89 1 91.8% 31.7% 27:341 18:361
--------------------------RDSSKRVLTGCFLSLLIFTTLLGNTLVCVAVTKFRHLRsvTNFF
VISLAISDLLVAILVMPWKAATEIMGFWPFGE-FCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRY
ERKMTPKVACLMISVAWTLSVLISFIPVQLNWHKAQTASYvaGDLPPDNCDSSLNRTYAISSSLISFYIP
VAIMIVTYTRIYRIAQKQIRRISALERaeSECSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCMVP
FCepCISSTTFDVFVWFGWANSSLNPIIYAF-NADFRKAFSILLGCHRLCPGNSAIEIVSI
>77:Q13639 5-hydroxytryptamine receptor 4 OS=Homo sapiens OX=9606 GN=HTR4 PE=1 SV=2 2 274 7e-89 1 90.6% 35.5% 17:326 5:329
----------------DANVSSEEGFGSVE-KVVLLTFLSTVILMAILGNLLVMVAVCWDRQLRKitNYF
IVSLAFADLLVSVLVMPFGAIELVQDIWIYGEVFCLVRTSLDVLLTTASIFHLCCISLDRYYAIcqPLVY
RNKMTPLRIALMLGGCWVIPTFISFLPIMQGWNNIGIIDLIEknSNSTYCVFMVNKPYAITCSVVAFYIP
FLLMVLAYYRIYVTAKEHAHQIQMLQrqSADQHSTHRMRTETKAAKTLCIIMGCFCLCWAPFFVTNIVDP
FIDYTVPGQVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCC---------------
>78:Q9TST6 Beta-1 adrenergic receptor OS=Felis catus OX=9685 GN=ADRB1 PE=3 SV=1 2 277 8e-89 1 89.4% 34.0% 21:326 45:389
--------------------PTSEGPAPLSQQWtiGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLF
IMSLASADLVMGLLVVPFGATIVMRGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRY
QSLLTRARARALVCTVWAISALVSFLPILMHWWRAEGDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVP
LCIMAFVYLRVFREAQKQVKKIDSCERrsKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKA
FHRDLVPDRLFVFFNWLGYANSAFNPIIY-CRSPDFRKAFQRLLCF---------------
>79:Q28998 Beta-1 adrenergic receptor OS=Sus scrofa OX=9823 GN=ADRB1 PE=2 SV=2 2 275 6e-88 1 91.5% 33.4% 10:326 39:383
---------PASLLTPASEGSVQLSQQWTAG---MGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLF
IMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRY
QSLLT-RAARALVCTVWAISALVSFLPILMHWWRDKGAEARRCYNDPKCCDFVTNRAYAIASSVVSFYVP
LCIMAFVYLRVFREAQKQVKKIDSCERrsKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKA
FHRDLVPDRLFVFFNWLGYANSAFNPIIY-CRSPDFRKAFQRLLCC---------------
>80:Q8BLD9 D(1B) dopamine receptor OS=Mus musculus OX=10090 GN=Drd5 PE=2 SV=1 2 274 2e-87 1 90.3% 31.6% 30:339 36:385
-----------------------------PAQVVTAGLLTLLIVWTLLGNVLVCAAIVRSRHLRamTNIF
IVSLAVSDLFVALLVMPWKAVAEVAGYWPFG-AFCDIWVAFDIMCSTASILNLCIISVDRYWAISRPFRY
ERKMTQRVALVMVALAWTLSILISFIPVQLNwnETPWEEGWELDGRTENCDSSLNRTYAISSSLISFYIP
VAIMIVTYTRIYRIAQVQIRRISSLERAAEHAQSCRSrkKETKVFKTLSVIMGVFVCCWLPFFILNCMVP
FCSscVSETTFDIFVWFGWANSSLNPIIYAF-NADFRKVFAQLLGCscFRTPVQTVNIS--
>81:Q62758 5-hydroxytryptamine receptor 4 OS=Rattus norvegicus OX=10116 GN=Htr4 PE=2 SV=1 2 271 2e-87 1 90.6% 34.2% 17:326 5:329
----------------DANVSSNEGFGSVE-KVVLLTFFAMVILMAILGNLLVMVAVCRDRQLRKitNYF
IVSLAFADLLVSVLVNAFGAIELVQDIWFYGEMFCLVRTSLDVLLTTASIFHLCCISLDRYYAIcqPLVY
RNKMTPLRIALMLGGCWVIPMFISFLPIMQGWNNIGIVDVIEknSNSTFCVFMVNKPYAITCSVVAFYIP
FLLMVLAYYRIYVTAKEHAQQIQMLQrqTADQHSTHRMRTETKAAKTLCVIMGCFCFCWAPFFVTNIVDP
FIDYTVPEKVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCC---------------
>82:P25115 D(1B) dopamine receptor OS=Rattus norvegicus OX=10116 GN=Drd5 PE=2 SV=1 2 273 2e-87 1 90.3% 31.9% 30:339 36:385
-----------------------------PAQVVTAGLLTLLIVWTLLGNVLVCAAIVRSRHLRamTNIF
IVSLAVSDLFVALLVMPWKAVAEVAGYWPFG-TFCDIWVAFDIMCSTASILNLCIISVDRYWAISRPFRY
ERKMTQRVALVMVGLAWTLSILISFIPVQLNwnGTPWEEGWELEGRTENCDSSLNRTYAISSSLISFYIP
VAIMIVTYTRIYRIAQVQIRRISSLERAAEHAQSCRSrkKETKVFKTLSMIMGVFVCCWLPFFILNCMVP
FCSscVSETTFDIFVWFGWANSSLNPIIYAF-NADFRKVFAQLLGCscFRTPVQTVNIS--
>83:P42290 D(1B) dopamine receptor OS=Xenopus laevis OX=8355 GN=drd5 PE=2 SV=1 2 272 6e-87 1 92.7% 31.1% 9:326 18:361
--------SPEMLMNKSVSRESQRRKELVAGQIVTGSLLLLLIFWTLFGNILVCTAVMRFRHLRsvTNIF
IVSLAVSDLLVALLVMPWKAVAEVAGHWPFG-AFCDIWVAFDIMCSTASILNLCVISVDRYWAISSPFRY
ERKMTQRVALLMISTAWALSVLISFIPVQLSWHKSETEDHLLSNHSTGNCDSSLNRTYAISSSLISFYIP
VAIMIVTYTRIYRIAQIQIKRIsdSCSRHHQTSLRTSIKKETKVLKTLSIIMGVFVCCWLPFFILNCMVP
FCDrcVSETTFDIFVWFGWANSSLNPIIYAF-NADFRKVFSSLLGC---------------
>84:P47800 D(1)-like dopamine receptor OS=Oreochromis mossambicus OX=8127 PE=2 SV=1 2 267 3e-86 1 90.3% 30.8% 20:334 23:348
-------------------GTDSPRTSDLSLRALTGCVLCILIVSTLLGNALVCAAVIKFRHLRsvTNAF
VISLAVSDLFVAVLVMPWRAVSEVAGVWLFG-AFCDTWVAFDIMCSTASILHLCIISMDRYWAISSPFRY
ERRMTPRFGCVMIGVAWTLSVLISFIPVQLNWHARGRERTDP-----GDCNASLNRTYAISSSLISFYIP
VLIMVGTYTRIFRIGRTQIRRISSLERadEESSLKTSFRRETKVLKTLSVIMGVFVFCWLPFFVLNCMVP
FCRlcVSDTTFSVFVWFGWANSSLNPVIYAF-NADFRKAFSTILGCSRYCRTSA-------
>85:Q9P1P4 Putative trace amine-associated receptor 3 OS=Homo sapiens OX=9606 GN=TAAR3P PE=5 SV=1 2 266 4e-86 1 85.9% 46.8% 47:339 46:339
----------------------------------------------LFGNLVIMVSISHFKQLHSPTNFL
ILSMATTDFLLGFVIMPYSIMRSVESCWYFGDGFCKFHTSFDMMLRLTSIFHLCSIAIDRFYAVCYPLHY
TTKMTNSTIKQLLAFCWSVPALFSFGLVLSEADVSGMQSYKILVACFNFCALTFNKFWGTILFTTCFFTP
GSIMVGIYGKIFIVSKQHARVISHVPENTKGAVKKHLSKKkrKAAKTLGIVMGVFLACWLPCFLAVLIDP
YLDYSTPILILDLLVWLRYFNSTCNPLIHGFFNPWFQKAFKYIVSGKIFSSHSETANLF--
>86:P34971 Beta-1 adrenergic receptor OS=Mus musculus OX=10090 GN=Adrb1 PE=1 SV=2 2 270 5e-86 1 80.6% 35.9% 49:324 75:380
------------------------------------------------GNVLVIVAIAKTPRLQTLTNLF
IMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRY
QSLLTRARARALVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVP
LCIMAFVYLRVFREAQKQVKKIDSCERrsKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKA
FHRDLVPDRLFVFFNWLGYANSAFNPIIY-CRSPDFRKAFQRLL-----------------
>87:P42289 D(1A) dopamine receptor OS=Xenopus laevis OX=8355 GN=drd1 PE=2 SV=1 2 269 5e-86 1 94.4% 30.9% 13:336 3:360
------------FNITSMDEDVLLTERESSFRVLTGCFLSVLILSTLLGNTLVCAAVIRFRHLRsvTNFF
VISLAVSDLLVAVLVMPWKAVAEIAGFWPFG-TFCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRY
ERKMTPKVAFIMIGVAWTLSVLISFIPVQLNWHKAKTTSFFDLnrTMDNCDSSLNRTYAISSSLISFYIP
VAIMIVTYTRIYRIAAKQIRRISALErqQPESSLKTSFKRETKVLKTLSVIMGVFVCCWLPFFILNCIVP
FCdfCISSTTFDVFVWFGWANSSLNPIIYAF-NADFRKAFSNLLGCYRLCPTSNNI-----
>88:Q9VCZ3 Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1 2 271 7e-86 1 88.3% 32.1% 24:325 99:420
-----------------------DGSSHLALVFVKCFIIGFIILAAILGNMLVIVSVMRHRKLRIITNYF
VVSLAVADMLVALCAMTFNASVMISGKWMFGSVMCDMWNSFDVYFSTASIMHLCCISVDRYYAIVQPLDY
PLIMTQRRVFIMLLMVWLSPALLSFLPICSGW-YTTTENYKYLKSNPHICEFKVNKAYAIVSSSMSFWIP
GIVMLSMYYRIYQEADRQERLVYRspSIQVEQSTISTMRRERKAARTLGIIMSAFLICWLPFFLWYIVSS
LCdcITPRLLVGILFWIGYFNSALNPIIYAYFNRDFRAAFKKTLK----------------
>89:P18090 Beta-1 adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adrb1 PE=1 SV=1 2 268 2e-85 1 80.6% 35.9% 49:324 75:380
------------------------------------------------GNVLVIVAIAKTPRLQTLTNLF
IMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITLPFRY
QSLLTRARARALVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVP
LCIMAFVYLRVFREAQKQVKKIDSCERrsKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKA
FHRDLVPDRLFVFFNWLGYANSAFNPIIY-CRSPDFRKAFQRLL-----------------
>90:P08588 Beta-1 adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRB1 PE=1 SV=2 2 268 2e-85 1 88.0% 34.6% 21:321 45:388
--------------------PASESPEPLSQQWtmGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLF
IMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRY
QSLLTRARARGLVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVP
LCIMAFVYLRVFREAQKQVKKIDSCERrgKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKA
FHRELVPDRLFVFFNWLGYANSAFNPIIY-CRSPDFRKAFQ--------------------
>91:P41596 Dopamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=Dop1R1 PE=2 SV=2 2 269 3e-85 1 88.6% 30.6% 24:327 135:464
-----------------------PEPLSLVSIVVVGIFLSVLIFLSVAGNILVCLAIYTERSLRRIGNLF
LASLAIADLFVASLVMTFAGVNDLLGYWIFGAQFCDTWVAFDVMCSTASILNLCAISMDRYIHIKDPLRY
GRWVTRRVAVITIAAIWLLAAFVSFVPiiHRPDQPLIFEDNGKKY--PTCALDLTPTYAVVSSCISFYFP
CVVMIGIYCRLYCYAQKHVKSIKAVTrrNLHTHSSPYHVSDHKAAVTVGVIMGVFLICWVPFFCVNITAA
FCKTCIGGQTFKILTWLGYSNSAFNPIIYSIFNKEFRDAFKRILTMR--------------
>92:Q9TST4 Beta-3 adrenergic receptor OS=Felis catus OX=9685 GN=ADRB3 PE=3 SV=1 2 265 5e-85 1 94.4% 34.5% 8:332 15:368
-------PDAPTLTPNTANTSGLPGVPWAVALAGALLALAVLATVG--GNLLVIVAIARTPRLQTMTNVF
VTSLATADLVVGLLVVPPGATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRY
GALVTKRRARAAVVLVWVVSAAVSFAPIMSKWWRVGADAEAQRCHSNPHCCAfsNIPYALLSSSVSFYLP
LLVMLFVYARVFVVATRQLRLLrpAASRSMSPAPAGPCAseHRALRTLGLIMGTFSLCWLPFFVANVVRA
LGGPsvPSPAFLALNWLGYANSAFNPLIY-CRSPDFRSAFRRLLCRCRLEER---------
>93:P25962 Beta-3 adrenergic receptor OS=Mus musculus OX=10090 GN=Adrb3 PE=2 SV=2 2 263 2e-84 1 90.6% 34.8% 16:325 18:358
---------------PTLDPSAANTSGLPGVPWAAALAGALLALATVGGNLLVIIAIARTPRLQTITNVF
VTSLAAADLVVGLLVMPPGATLALTGHWPLGETGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRY
GTLVTKRRARAAVVLVWIVSAAVSFAPIMSQWWRVGAdeAQECHSNPRCCSFASNMPYALLSSSVSFYLP
LLVMLFVYARVFVVAKRQRHLLRRELGrcGRRPARLLPLREHRALRTLGLIMGIFSLCWLPFFLANVLRA
LAGPsvPSGVFIALNWLGYANSAFNPVIY-CRSPDFRDAFRRLLC----------------
>94:P23944 Alpha-1D adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adra1d PE=2 SV=2 2 268 3e-84 1 91.2% 33.5% 2:320 59:407
-DNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGvvGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYF
IVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKY
PAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERF--------CGITEEVGYAIFSSVCSFYLP
MAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEvkFSREKKAAKTLAIVVGVFVLCWFPFfvLPLGSL
FPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAF---------------------
>95:P47899 Beta-1 adrenergic receptor OS=Macaca mulatta OX=9544 GN=ADRB1 PE=3 SV=1 2 266 3e-84 1 88.0% 34.6% 21:321 45:391
--------------------PASEGPEPLSQQWtmGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLF
IMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRY
QSLLTRARARGLVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVP
LCIMAFVYLRVFREAQKQVKKIDSCERrgKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKA
FHRELVPDRLFVFFNWLGYANSAFNPIIY-CRSPDFRNAFQ--------------------
>96:Q9TTM9 Alpha-1D adrenergic receptor OS=Sus scrofa OX=9823 GN=ADRA1D PE=3 SV=1 2 267 5e-84 1 88.9% 33.8% 18:328 80:421
-----------------VNGTAAVGGLVVSAQGvvGVFLAAFILMAVAGNLLVILSVACNRHLQTVTNYF
IVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKY
PSIMTERKAAAILALLWAVAIVVSVGPLLGWKEPVPPDERF--------CGITEEAGYAVFSSLCSFYLP
MAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEvkFSREKKAAKTLAIVVGVFVLCWFPFfvLPLGSL
FPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQC-------------
>97:P97292 Histamine H2 receptor OS=Mus musculus OX=10090 GN=Hrh2 PE=2 SV=2 2 262 9e-84 1 88.6% 30.2% 28:338 14:316
---------------------------SIALKVTISVVLTTLIFITVAGNVVVCLAVSLNRRLRSLTNCF
IVSLAATDLLLGLLVMPFSAIYQLSFKWSFGQVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRY
PVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTF---KCKVQVNEVYGLVDGMVTFYLP
LLIMCVTYYRIFKIAREQAKRINHISS------WKAATIREHKATVTLAAVMGAFIVCWFPYFTAFVYRG
LRGDDAVNEVVeiVLWLGYANSALNPILYATLNRDFRMAYQQLFHCKLASHNSHKTSL---
>98:P42291 D(1C) dopamine receptor OS=Xenopus laevis OX=8355 GN=drd1c PE=2 SV=1 2 263 1e-83 1 82.4% 32.9% 50:332 46:350
-------------------------------------------------NTLVCLAVIKFRHLRsvTNFF
VISLAVSDLFVALLVMPWKAVTEVAGFWVFGD-FCDTWVAFDIMCSTASILNLCIISLDRYWAIASPFRY
ERKMTQRVAFIMIGVAWTLSILISfpVQLSWHKSHEADEELNGVNHTENCDSSLNRTYAISSSLISFYIP
VVIMIGTYTRIYRIAQTQIRRIscSSRLSNENSLKTSFRKETKVLKTLSIIMGVFVFCWLPFFVLNCMIP
FCHMNLpeTTFNIFVWFGWANSSLNPVIYAF-NADFRKAFTTILGCNRFCSS---------
>99:Q95136 D(1A) dopamine receptor OS=Bos taurus OX=9913 GN=DRD1 PE=2 SV=2 2 262 4e-83 1 93.0% 31.0% 17:335 3:356
----------------TLNTSTMEGTGLVAERDFSFRILTACFLSLLigNTLVCAAVIRFRHLRsvTNFF
VISLAVSDLLVAVLVMPWKAVAEIAGFWPFGS-FCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRY
ERKMTPKAAFILISVAWTLSVLISFIPvwHKAKPTGPSeaTSLGKTINNCDSSLSRTYAISSSLISFYIP
VAIMIVTYTRIYRIAQKQIRRIspMECSQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCMVP
FCgfCIDSITFDVFVWFGWANSSLNPIIYAF-NADFRKAFSTLLGCYRLCPTTNN------
>100:P50130 D(1A) dopamine receptor OS=Sus scrofa OX=9823 GN=DRD1 PE=3 SV=1 2 261 5e-83 1 93.0% 30.7% 17:335 3:356
----------------TLNTSTMDGTGLVVERDFSFRILTACFLSLLigNTLVCAAVIRFRHLRsvTNFF
VISLAVSDLLVAVLVMPWKAVAEIAGFWPFGS-FCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRY
ERKMTPKAAFILISVAWTLSVLISFIPVqaKPTSPSDGNVTSLGKTTHNCDSSLSRTYAISSSLISFYIP
VAIMIVTYTRIYRIAQKQIRRIspAECSQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCMVP
FCgfCIDSITFDVFVWFGWANSSLNPIIYAF-NADFRKAFSTLLGCYRLCPTSTN------
>101:P42288 D(1A) dopamine receptor OS=Didelphis virginiana OX=9267 GN=DRD1 PE=2 SV=1 2 261 1e-82 1 90.0% 30.1% 27:335 17:359
--------------------------RDFSFRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRsvTNFF
VISLAVSDLLVAVLVMPWKAVAEIAGFWPFGS-FCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRY
ERKMTPKAAFILISVAWTLSVLISFIPVqaRPLSSPDGNVSSQDETMDNCDSSLSRTYAISSSLISFYIP
VAIMIVTYTRIYRIAQKQIRRISALErsQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCMVP
FCefCIDSITFDVFVWFGWANSSLNPIIYAF-NADFRKAFSTLLGCYRLCPTANN------
>102:P21728 D(1A) dopamine receptor OS=Homo sapiens OX=9606 GN=DRD1 PE=1 SV=1 2 260 2e-82 1 91.8% 29.8% 17:331 8:352
----------------AMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRsvTNFF
VISLAVSDLLVAVLVMPWKAVAEIAGFWPFGS-FCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRY
ERKMTPKAAFILISVAWTLSVLISFIPVqaKPTSPSDGNATSLAETIDNCDSSLSRTYAISSSVISFYIP
VAIMIVTYTRIYRIAQKQIRRIAALErsQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILP
FCgfCIDSNTFDVFVWFGWANSSLNPIIYAF-NADFRKAFSTLLGCYRLCP----------
>103:P21918 D(1B) dopamine receptor OS=Homo sapiens OX=9606 GN=DRD5 PE=1 SV=2 2 261 2e-82 1 82.7% 29.9% 49:332 57:381
------------------------------------------------GNVLVCAAIVRSRHLrnMTNVF
IVSLAVSDLFVALLVMPWKAVAEVAGYWPFG-AFCDVWVAFDIMCSTASILNLCVISVDRYWAISRPFRY
KRKMTQRMALVMVGLAWTLSILISFIPvwHRDQAASweDFWEPDVNAENCDSSLNRTYAISSSLISFYIP
VAIMIVTYTRIYRIAQVQIRRISSLERAAEHAQSCRSskKETKVLKTLSVIMGVFVCCWLPFFILNCMVP
FCspCVSETTFDVFVWFGWANSSLNPVIYAF-NADFQKVFAQLLGCSHFCSR---------
>104:G3M4F8 Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1 2 258 2e-82 1 86.5% 33.9% 38:335 43:364
-------------------------------------VLLLIVIMAVLGNMLVIVSVMRHRKLRVITNYF
VVSLAFADILVAMVVMPFNFSVQFNQGWVFGETICDLWNSSDVYFTSTSILHLCCISVDRYYAIVKPLKY
PIKMTKKMAFVMLAATWLSPITISYVPIFMGWYTT---TDFLESRRDDQCEFKVNKPYAVISSSISFWIP
CTIMIFTYLAIFKEANRQEKALHARAGNAMLMHRHSrmKREHKAARTLGIIMGAFILCWLPFFLYYVSTS
LCdcNCPEVVTVIMFWTGYFNSALNPIIYAYFNRDFRNAFKNTLAccSFCKRSAS------
>105:P60021 Histamine H2 receptor OS=Pan troglodytes OX=9598 GN=HRH2 PE=3 SV=1 2 256 3e-82 1 88.3% 32.0% 32:340 18:319
-------------------------------KITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTNCF
IVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPLRY
PVLVTPVRVAISLVLIWVISITLSFLSIHLGWN--SRNETSKGNHTTSKCKVQVNEVYGLVDGLVTFYLP
LLIMCITYYRIFKVARDQAKRINHISS------WKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRG
LRGDDAINEVLEAilWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSLRS-
>106:P61752 Histamine H2 receptor OS=Pongo pygmaeus OX=9600 GN=HRH2 PE=3 SV=1 2 256 3e-82 1 88.3% 32.0% 32:340 18:319
-------------------------------KITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTNCF
IVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPLRY
PVLVTPVRVAISLVLIWVISITLSFLSIHLGWN--SRNETSKGNHTTSKCKVQVNEVYGLVDGLVTFYLP
LLIMCITYYRIFKVARDQAKRINHISS------WKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRG
LRGDDAINEVLEAilWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSLRS-
>107:Q76MS7 Histamine H2 receptor OS=Gorilla gorilla gorilla OX=9595 GN=HRH2 PE=3 SV=1 2 256 3e-82 1 88.3% 32.0% 32:340 18:319
-------------------------------KITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTNCF
IVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPLRY
PVLVTPVRVAISLVLIWVISITLSFLSIHLGWN--SRNETSKGNHTTSKCKVQVNEVYGLVDGLVTFYLP
LLIMCITYYRIFKVARDQAKRINHISS------WKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRG
LRGDDAINEVLEAilWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSLRS-
>108:P25021 Histamine H2 receptor OS=Homo sapiens OX=9606 GN=HRH2 PE=2 SV=1 2 256 3e-82 1 88.3% 32.0% 32:340 18:319
-------------------------------KITITVVLAVLILITVAGNVVVCLAVGLNRRLRNLTNCF
IVSLAITDLLLGLLVLPFSAIYQLSCKWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVMDPLRY
PVLVTPVRVAISLVLIWVISITLSFLSIHLGWN--SRNETSKGNHTTSKCKVQVNEVYGLVDGLVTFYLP
LLIMCITYYRIFKVARDQAKRINHISS------WKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRG
LRGDDAINEVLEAilWLGYANSALNPILYAALNRDFRTGYQQLFCCRLANRNSHKTSLRS-
>109:O77680 D(1A) dopamine receptor OS=Macaca mulatta OX=9544 GN=DRD1 PE=3 SV=1 2 259 3e-82 1 91.8% 29.8% 17:331 8:352
----------------AMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRsvTNFF
VISLAVSDLLVAVLVMPWKAVAEIAGFWPFGS-FCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRY
ERKMTPKAAFILISVAWTLSVLISFIPVqaKPTSPSDGNATSLAETIDNCDSSLSRTYAISSSVISFYIP
VAIMIVTYTRIYRIAQKQIRRIAALErsQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILP
FCgfCIDSITFDVFVWFGWANSSLNPIIYAF-NADFRKAFSTLLGCYRLCP----------
>110:P97714 Alpha-1D adrenergic receptor OS=Mus musculus OX=10090 GN=Adra1d PE=2 SV=1 2 262 7e-82 1 86.5% 34.3% 18:320 75:407
-----------------VNGSAAVGGLVVSAQGvvGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYF
IVNLAVADLLLSAAVLPFSATMEVLGFWPFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKY
PAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERF--------CGITEEVGYAIFSSVCSFYLP
MAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEvkFSREKKAAKTLAIVVGVFVLCWFPFfvLPLGSL
FPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAF---------------------
>111:Q95252 Beta-3 adrenergic receptor OS=Sus scrofa OX=9823 GN=ADRB3 PE=2 SV=2 2 256 1e-81 1 94.4% 34.2% 8:332 15:368
-------PDVSTLAPNNANTSGLPGVPWAVALAGALLAPAVLATVG--GNLLVIVAIARTPRLQTMTNVF
VTSLATADLVVGLLVVPPGTTLALTGHWPLGATCCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRY
GALVTKRRARAAVVLVWVVSAAVSFAPIMSKWWRVGAdeAQRCHSNPSCCTFASNMPYALLSSSVSFYLP
LLVMLFVYARVFVVATSQLRLLraGVPSHGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFVVNVVRA
LGGPsvPVPAFLALNWLGYANSAFNPLIY-CHSPDFRSAFRRLLCRCGPEEH---------
>112:P35406 D(1) dopamine receptor OS=Carassius auratus OX=7957 PE=2 SV=1 2 255 1e-81 1 88.6% 32.9% 30:333 22:352
-----------------------------SVRVLTGCFLSVLILSTLLGNTLVCAAVTKFRHLRsvTNFF
VISLAVSDLLVAVLVMPWKAVTEVAGFWPFG-AFCDIWVAFDIMCSTASILNLCVISVDRYWAISSPFRY
ERKMTPRVAFVMISGAWTLSVLISFIPvwHKAQPIGFLEVNASRrpTDNCDSSLNRTYAISSSLISFYIP
VAIMIVTYTQIYRIAQKQIRRISALERAAeeSSFKLSFKRETKVLKTLSVIMGVFVCCWLPFFILNCMVP
FCKrcISPTTFDVFVWFGWANSSLNPIIYAF-NADFRRAFAILLGCQRLCPGS--------
>113:Q4LBB9 Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2 2 260 2e-81 1 84.5% 30.3% 37:326 158:482
------------------------------------FVMLLIIIAAICGNLLVIISVMRVRKLRVITNYF
VVSLAMADIMVAIMAMTFNFSVQVTGRWNFSPFLCDLWNSLDVYFSTASILHLCCISVDRYYAIVKPLKY
PISMTKRVVGIMLLNTWISPALLSFLPIfgWYTTPQHQQFV--IQNPTQCSFVVNKYYAVISSSISFWIP
CTIMIFTYLAIFREANRQEKQLMMRHGnpTKDKHLIKMKREHKAARTLGIIMGTFILCWLPFFLWYTLSM
TceCQVPDIVVSILFWIGYFNSTLNPLIYAYFNRDFREAFRNTLLC---------------
>114:Q28524 Beta-3 adrenergic receptor OS=Macaca mulatta OX=9544 GN=ADRB3 PE=2 SV=1 2 257 2e-81 1 90.3% 33.8% 17:327 24:363
----------------TANTSGLPGVPWAAALAGALLALAVLATVG--GNLLVIVAITRTPRLQTMTNVF
VTSLAAADLVMGLLVVPPAATLVLTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRY
GALVTKRRARAAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAfsNMPYVLLSSSVSFYLP
LLVMLFVYARVFVVATRQLRLLrtCAPPEGVPACCRRParEHRALCTLGLIMGTFTLCWLPFFLANVLRA
LGGPsvPDPAFLALNWLGYANSAFNPLIY-CRSPDFRSAFRRLLCHC--------------
>115:Q60484 5-hydroxytryptamine receptor 1D OS=Cavia porcellus OX=10141 GN=HTR1D PE=3 SV=1 2 255 2e-81 1 93.3% 33.2% 3:327 5:373
--NQSEEGLPQEASNRSLNATETPGDWDpaLKVSLVVVLSIITLATVLSNAFVLTTILLTRKLHTPANYL
IGSLATTDLLVSILVMPISIAYTTTRTWNFGQILCDIWVSSDITCCTASILHLCVIALDRYWAITDALEY
SKRRTAGHAGAMIAAVWVISICISIPPLF-------WRQAQAQEEMSDCLVNTSQISYTIYSTCGAFYIP
SVLLIILYSRIYRAARSRipSLHEGHMHPGSPLFFNHVrrERKATKTLGIILGAFIVCWLPFFVVSLVLP
ICRDSchPALFDFFTWLGYLNSLINPIIYTVFNEDFRQAFQKVVHFR--------------
>116:Q61616 D(1A) dopamine receptor OS=Mus musculus OX=10090 GN=Drd1 PE=1 SV=2 2 256 7e-81 1 93.0% 28.8% 17:335 7:356
----------------TMDETGLPVERDFSFRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRsvTNFF
VISLAVSDLLVAVLVMPWKAVAEIAGFWPFGS-FCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFQY
ERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTWPLDGNFTsdNCDTRLSRTYAISSSLISFYIP
VAIMIVTYTSIYRIAQKQIRRISALErsQSESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFISNCMVP
FCgfCIDSITFDVFVWFGWANSSLNPIIYAF-NADFQKAFSTLLGCYRLCPTTNN------
>117:P18901 D(1A) dopamine receptor OS=Rattus norvegicus OX=10116 GN=Drd1 PE=1 SV=2 2 255 7e-81 1 93.0% 28.8% 17:335 7:356
----------------TMDEAGLPAERDFSFRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRsvTNFF
VISLAVSDLLVAVLVMPWKAVAEIAGFWPLGP-FCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFQY
ERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTWPLDGNFTsdNCDTRLSRTYAISSSLISFYIP
VAIMIVTYTSIYRIAQKQIRRISALEraQSESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFISNCMVP
FCgfCIDSITFDVFVWFGWANSSLNPIIYAF-NADFQKAFSTLLGCYRLCPTTNN------
>118:Q588Y6 5-hydroxytryptamine receptor 1B OS=Felis catus OX=9685 GN=HTR1B PE=2 SV=1 2 254 8e-81 1 92.1% 32.1% 2:328 24:387
-NLSSAPPNCSTEGYIYQDSIALPW------KVLLILVLALFTLATTLSNAFVIATVYRTRKLHTPANYL
IASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEY
SAKRTPKRAAVMIALVWVFSISISLPPFF-------WRQAKAEEEVSDCRVNTDHMLYTVYSTVGAFYFP
TLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDseRKATKTLGIILGAFIVCWLPFFIISLVMP
ICKDACWfaIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>119:P17124 Histamine H2 receptor OS=Canis lupus familiaris OX=9615 GN=HRH2 PE=1 SV=1 2 252 1e-80 1 89.4% 31.6% 28:340 14:319
---------------------------SPPCRITVSVVLTVLILITIAGNVVVCLAVGLNRRLRSLTNCF
IVSLAITDLLLGLLVLPFSAFYQLSCRWSFGKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRY
PVLITPVRVAVSLVLIWVISITLSFLSIHLGWN--SRNETSSFNHTIPKCKVQVNLVYGLVDGLVTFYLP
LLVMCITYYRIFKIARDQAKRIHHMGS------WKAATIGEHKATVTLAAVMGAFIICWFPYFTVFVYRG
LKGDDAINEAFEavLWLGYANSALNPILYATLNRDFRTAYQQLFRCRPASHNAQETSLRS-
>120:Q8UUY8 Beta-2 adrenergic receptor OS=Oncorhynchus mykiss OX=8022 GN=adrb2 PE=2 SV=1 2 254 2e-80 1 90.9% 33.1% 17:327 18:351
----------------EMNSSSRQWSYSEYSEAvlGILMALLVMCIVFGNVLVITAIVRFQRLQTVTNMF
ITSLACADLVMGLLVVPFGACYILLNTWHFGSFLCEFWTAADVLCVTASIETLCVIALDRYLAITSPLRY
PSLLTKRKACVVVVTVWGVAALISFLPIHMKWWVSDEPEALSCLEDAHCCDFNTNAAYAVASSVVSFYIP
LAVMAFVYGRVFQEARKQLEKIRGSEGRFHAQMIDNncLKEHKALKTLGIIMGTFTLCWLPFFVLNVVVT
IWKVDNIKMPFRILNWIGYANSAFNPLIY-CRSPEFRYAFQEILCLR--------------
>121:P49145 5-hydroxytryptamine receptor 1D OS=Oryctolagus cuniculus OX=9986 GN=HTR1D PE=3 SV=1 2 252 3e-80 1 93.5% 32.5% 2:327 4:374
-SNQSAEGLPQEAANRSLNATGTPEAWDpaLKISLAVVLSIITVATVLSNTFVLTTILLTRKLHTPANYL
IGSLATTDLLVSILVMPISIAYTITHTWNFGQVLCDIWVSSDITCCTASILHLCVIALDRYWAITDALEY
SKRRTAGHAAAMIAVVWAISICISIPPLF-WRQAKAHEEVSDCLVNTSQIS------YTIYSTCGAFYIP
SVLLIVLYGRIYMAARNRILNPPshSHSAGSPLFFNPVrrERKATKTLGIILGAFIGCWLPFFVASLVLP
ICRDScpPGLFDFFTWLGYLNSLINPIIYTVFNEDFRQAFQRVIHFR--------------
>122:P28222 5-hydroxytryptamine receptor 1B OS=Homo sapiens OX=9606 GN=HTR1B PE=1 SV=1 2 252 3e-80 1 90.9% 32.9% 10:328 29:388
---------PSQNC--SAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYL
IASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEY
SAKRTPKRAAVMIALVWVFSISISLPPFF-------WRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFP
TLLLIALYGRIYVEARSRiqLITDSPGSTSSVTSINSraRERKATKTLGIILGAFIVCWLPFFIISLVMP
ICKDACWfaIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>123:P60020 5-hydroxytryptamine receptor 1B OS=Pan troglodytes OX=9598 GN=HTR1B PE=3 SV=1 2 252 3e-80 1 90.9% 32.9% 10:328 29:388
---------PSQNC--SAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYL
IASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEY
SAKRTPKRAAVMIALVWVFSISISLPPFF-------WRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFP
TLLLIALYGRIYVEARSRiqLITDSPGSTSSVTSINSraRERKATKTLGIILGAFIVCWLPFFIISLVMP
ICKDACWfaIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>124:O02666 Alpha-1D adrenergic receptor OS=Oryctolagus cuniculus OX=9986 GN=ADRA1D PE=2 SV=1 2 257 4e-80 1 86.5% 34.3% 18:320 86:418
-----------------VNGTAAVGGLVVSAQSvvGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYF
IVNLAVADLLLSATVLPFSATMEVLGFWAFGRAFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKY
PAIMTERKAAAILALLWAVALVVSMGPLLGWKEPVPPDERF--------CGITEEVGYAVFSSLCSFYLP
MAVIVVMYCRVYVVARSTTRSLEAGVKRERGKASEvkFSREKKAAKTLAIVVGVFVLCWFPFfvLPLGSL
FPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAF---------------------
>125:P26255 Beta-3 adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adrb3 PE=2 SV=2 2 252 6e-80 1 90.6% 34.2% 16:325 18:358
---------------PTLDPSAANTSGLPGVPWAAALAGALLALATVGGNLLVITAIARTPRLQTITNVF
VTSLATADLVVGLLVMPPGATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRY
GTLVTKRRARAAVVLVWIVSATVSFAPIMSQWWRVGAdeAQECHSNPRCCSFASNMPYALLSSSVSFYLP
LLVMLFVYARVFVVAKRQrpTASDGVPSCGRRPARLLPLGEHRALRTLGLIMGIFSLCWLPFFLANVLRA
LVGPsvPSGVFIALNWLGYANSAFNPLIY-CRSPDFRDAFRRLLC----------------
>126:Q9N2B7 5-hydroxytryptamine receptor 1B OS=Gorilla gorilla gorilla OX=9595 GN=HTR1B PE=3 SV=1 2 251 6e-80 1 90.9% 32.9% 10:328 29:388
---------PSQNC--SAKDYIYQDSIALPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYL
IASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEY
SAKRTPKRAAVMIALVWVFSISISLPPFF-------WRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFP
TLLLIALYGRIYVEARSRiqLITDSPGSTSSVTSINSraRERKATKTLGIILGAFIVCWLPFFIISLVMP
ICKDACWfaIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>127:P25102 Histamine H2 receptor OS=Rattus norvegicus OX=10116 GN=Hrh2 PE=3 SV=1 2 250 8e-80 1 88.6% 30.2% 28:338 14:316
---------------------------SMALKVTISVVLTTLILITIAGNVVVCLAVSLNRRLRSLTNCF
IVSLAATDLLLGLLVLPFSAIYQLSFTWSFGHVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRY
PVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTF---KCKVQVNEVYGLVDGLVTFYLP
LLIMCVTYYRIFKIAREQAKRINHISS------WKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRG
lgDDAINEAVEGIVLWLGYANSALNPILYAALNRDFRTAYQQLFHCKFASHNSHKTSL---
>128:Q9XT58 Beta-3 adrenergic receptor OS=Ovis aries OX=9940 GN=ADRB3 PE=3 SV=2 2 251 1e-79 1 91.8% 34.5% 17:332 24:368
----------------TANASGLPGVPWAVALAGALLALAVLATVG--GNLLVIVAIARTPRLQTMTNVF
VTSLATADLVVGLLVVPPGATLALTGHWPLGVTGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRY
GALVTKRRARAAVVLVWVVSAAVSFAPIMSKWWRVGAdeAQRCHSNPRCCTFASNMPYALLSSSVSFYLP
LLVMLFVYARVFVVATRQLRLLRRElpSYGRRPARLLPLREHRALRTLGLIMGTFTLCWLPFFVVNVVRA
LGGPSLVSgtFLALNWLGYANSAFNPLIY-CRSPDFRSAFRRLLCRCPPEEH---------
>129:P35404 5-hydroxytryptamine receptor 1B OS=Didelphis virginiana OX=9267 GN=HTR1B PE=2 SV=1 2 250 2e-79 1 93.0% 31.9% 2:327 15:385
-SLTSSQTNHSTFPNPNCSAPDLedSIALPWKVLLATFLGLITLGTTLSNAFVIATVSRTRKLHTPANYL
IASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEY
SAKRTPKRAAGMIIMVWVFSVSISMPPLFWRQ---------AKAEEVADCSVNTDhlYTVYSTVGAFYFP
TLLLIALYGRIYVEARSRisRAPEGPSESGSPVYVNQVkrERKATRTLGIILGAFIVCWLPFFIISLALP
ICDDACWfaIFDFFNWLGYLNSLINPIIYTKSNDDFKQAFQKLMRFR--------------
>130:Q93127 Probable G-protein coupled receptor No18 OS=Amphibalanus amphitrite OX=1232801 PE=3 SV=1 2 250 2e-79 1 93.3% 28.7% 3:326 1:374
--MSGGEASITGRTAPELNAspLDDERELGETVAATALLLAIILVTIVGNSLVIISVFTYRPLRSVQNFF
VVSLAVADLTVALFVLPLNVAYRLLNQWLLGSYLCQMWLTCDILCCTSSILNLCVIALDRYWAITDPINY
AQKRTIRRVNTMIAAVWALSLVISVPPLL------GWNDWPAQFTEDTPCTLTQERLFVVYSSSGSFFIP
LIIMSVVYAKIFFATKRRLRERTriSVHQFIEEKQRISLSKERKAARVLGVigVFVVCWLPFFLMYAIVP
FCTNCApqRVVDFVTWLGYVNSSLNPIIYTIYNKDFRTAFSRLLRC---------------
>131:Q9N2D9 5-hydroxytryptamine receptor 1F (Fragment) OS=Pan troglodytes OX=9598 GN=HTR1F PE=3 SV=1 2 248 5e-79 1 88.6% 29.3% 17:327 8:365
----------------DQNLTSEELLNRMPSKILVSLTLSGLALMTTTINSLVIAAIIVTRKLHHPANYL
ICSLAVTDFLVAVLVMPFSIVYIVRESWIMGQVVCDIWLSVDITCCTCSILHLSAIALDRYRAITDAVEY
ARKRTPKHAGIMITIVWIISVFISMPPLFWRHQGTSRDD---------ECIIKHBHIvtIYSTFGAFYIP
LALILILYYKIYRAAKTLYHKRQAssEFKHEKSWRRQKIseRKAATTLGLILGAFVICWLPFFVKELVVN
VCdcKISEEMSNFLAWLGYLNSLINPLIYTIFNEDFKKAFQKLVRCR--------------
>132:P28221 5-hydroxytryptamine receptor 1D OS=Homo sapiens OX=9606 GN=HTR1D PE=1 SV=1 2 249 6e-79 1 93.3% 32.3% 3:327 5:374
--NQSAEGLPQEASNRSLNATETSEAWDpaLKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYL
IGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEY
SKRRTAGHAATMIAIVWAISICISIPPLF-------WRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIP
SVLLIILYGRIYRAARNRisLHEGHSHSAGSPLFFNHVkrERKATKILGIILGAFIICWLPFFVVSLVLP
ICRDSchPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFR--------------
>133:O08890 5-hydroxytryptamine receptor 1F OS=Cavia porcellus OX=10141 GN=HTR1F PE=3 SV=1 2 248 6e-79 1 88.6% 29.3% 17:327 8:365
----------------DQNLTSEELLHRMPSKILVSLTLSGLALMTTTINSLVIAAIIVTRKLHHPANYL
ICSLAVTDFLVAVLVMPFSIVYIVRESWIMGQVLCDIWLSVDIICCTCSILHLSAIALDRYRAITDAVEY
ARKRTPKQAGIMITIVWIISVFISMPPLFWRHQGTSRDD---------ECIIKHDHIvtIYSTFGAFYIP
LVLILILYYKIYKAAKTLYHKRQASrkLRHEKSWRRQKIseRKAATTLGLILGAFVICWLPFFVKELVVN
VCecKISEEMANFLAWLGYLNSLINPLIYTIFNEDFKKAFQKLVRCQ--------------
>134:P30939 5-hydroxytryptamine receptor 1F OS=Homo sapiens OX=9606 GN=HTR1F PE=2 SV=1 2 248 7e-79 1 88.9% 29.2% 17:328 8:366
----------------DQNLTSEELLNRMPSKILVSLTLSGLALMTTTINSLVIAAIIVTRKLHHPANYL
ICSLAVTDFLVAVLVMPFSIVYIVRESWIMGQVVCDIWLSVDITCCTCSILHLSAIALDRYRAITDAVEY
ARKRTPKHAGIMITIVWIISVFISMPPLFWRHQGTSRDD---------ECIIKHDHIvtIYSTFGAFYIP
LALILILYYKIYRAAKTLYHKRQAssEFKHEKSWRRQKIseRKAATTLGLILGAFVICWLPFFVKELVVN
VCdcKISEEMSNFLAWLGYLNSLINPLIYTIFNEDFKKAFQKLVRCRC-------------
>135:Q9XT57 Beta-3 adrenergic receptor OS=Capra hircus OX=9925 GN=ADRB3 PE=3 SV=1 2 248 2e-78 1 91.8% 33.9% 17:332 24:368
----------------TANASGLPGVPWAVALAGALLALAVLAIVG--GNLLVIVAIARTPRLQTMTNVF
VTSLATADLVVGLLVVPPGATLALTGHWPLGVTGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRY
GALVTKRRARAAVVLVWVVSAAVSFAPIMSKWWRVGAdeAQRCHSNPRCCTFASNMPYALLSSSVSFYLP
LLVMLFVYARVFVVATRQLRLLRRElpSYGRRPARLLPLREHRALRTLGLIMGTFTLCWLPFFVVNVVRA
LGGPSLVSgtFLALNWLGYANSAFNPLIY-CRSPDFQSAFRRLLCRCRPEEH---------
>136:O02662 Beta-3 adrenergic receptor OS=Canis lupus familiaris OX=9615 GN=ADRB3 PE=2 SV=1 2 247 3e-78 1 88.3% 34.9% 17:320 24:356
----------------AANTSGLPGAPWAVALAGALLALEVLATVG--GNLLVIVAIARTPRLQTMTNVF
VTSLATADLVVGLLVVPPGATLALTGRWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRY
GALVTKRRARAAVVLVWVVSAAVSFAPIMSKWWRVGADAEAQRCHSNPHCCAfsNIPYALLSSSVSFYLP
LLVMLFVYARVFLVAtaRRCASPAAVPSDRLRPARLLPLREHRALRTLGLIVGTFTLCWLPFFVANVMRA
LGGPsvPSPALLALNWLGYANSAFNPLIY-CRSPDFRSAF---------------------
>137:P11614 5-hydroxytryptamine receptor 1D OS=Canis lupus familiaris OX=9615 GN=HTR1D PE=2 SV=1 2 247 3e-78 1 85.3% 34.9% 30:327 36:374
-----------------------------ALKISLALLLSIITMATALSNAFVLTTIFLTRKLHTPANYL
IGSLAMTDLLVSILVMPISIAYTTTRTWSFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEY
SKRRTAGRAAVMIATVWVISICISIPPLF-------WRQAKAQEDMSDCQVNTSQISYTIYSTCGAFYIP
SVLLIILYGRIYVAARNRicSLSPSLQEERSHAAGPPLfrERKATKTLGIILGAFIVCWLPFFVASLVLP
ICRASchPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQRVVHVR--------------
>138:Q0EAB5 5-hydroxytryptamine receptor 1B OS=Equus caballus OX=9796 GN=HTR1B PE=2 SV=1 2 246 9e-78 1 91.8% 32.0% 7:328 26:388
------SAAPSHNCSTE--GYVYQDSVALPWKVLLVVLLALITLATTLSNAFVIATVYRTRKLHTPANYL
IASLAVTDLLVSILVMPISTMYVVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEY
SAKRTPKRAAVMIALVWVFSISISLPPFF-------WRQAKAEEEVLDCLVNTDHILYTVYSTVGAFYFP
TLLLIALYSRIYVEARSRiqLMTDSPGSTSSVTSINSraRERKATKTLGIILGAFIVCWLPFFIISLVMP
ICKDACWfaIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>139:P79250 5-hydroxytryptamine receptor 1B OS=Canis lupus familiaris OX=9615 GN=HTR1B PE=2 SV=2 2 246 9e-78 1 92.1% 32.1% 2:328 24:387
-NLSSAPHNCSAEGYIYQDSVALPW------KVLLVILLALITLATTLSNAFVIATVYRTRKLHTPANYL
IASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDLWLSSDITCCTASILHLCVIALDRYWAITDAVEY
SAKRTPKRAAVMIALVWVFSISISLPPFF-------WRQAKAEEEVSDCVVNTDHILYTVYSTVGAFYFP
TLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDseRKATKTLGIILGAFIVCWLPFFIISLVMP
ICKDACWfaIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>140:Q6XXX8 5-hydroxytryptamine receptor 1B OS=Vulpes vulpes OX=9627 GN=HTR1B PE=3 SV=1 2 246 1e-77 1 92.1% 32.1% 2:328 24:387
-NLSSAPHNCSAEGYIYQDSIALPW------KVLLAILLALLTLATTLSNAFVIATVYRTRKLHTPANYL
IASLAVTDLLVSILVMPISTMYAVTGRWTLGQVVCDLWLSSDITCCTASILHLCVIALDRYWAITDAVEY
SAKRTPKRAAVMIALVWVFSISISLPPFF-------WRQAKAEEEVSDCVVNTDHILYTVYSTVGAFYFP
TLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDseRKATKTLGIILGAFIVCWLPFFIISLVMP
ICKDACWfaIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>141:P28334 5-hydroxytryptamine receptor 1B OS=Mus musculus OX=10090 GN=Htr1b PE=2 SV=1 2 245 2e-77 1 79.8% 34.8% 50:328 63:384
-------------------------------------------------NAFVIATVYRTRKLHTPANYL
IASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASIMHLCVIALDRYWAITDAVEY
SAKRTPKRAAIMIVLVWVFSISISLPPFF-------WRQAKAEEEMLDCFVNTDHVLYTVYSTVGAFYLP
TLLLIALYGRIYVEARSRiqLITDSPGSTSSVTSINSraRERKATKTLGIILGAFIVCWLPFFIISLVMP
ICKDACWfaIFDFFNWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>142:Q02284 5-hydroxytryptamine receptor 1F OS=Mus musculus OX=10090 GN=Htr1f PE=2 SV=1 2 244 2e-77 1 88.9% 29.3% 17:327 8:365
----------------DQNLTSEELLNRMPSKILVSLTLSGLALMTTTINSLVIAAIIVTRKLHHPANYL
ICSLAVTDFLVAVLVMPFSIVYIVRESWIMGQVLCDIWLSVDIICCTCSILHLSAIALDRYRAITDAVEY
ARKRTPRHAGIMITIVWVISVFISMPPLFWRHQGTSRDDECVIKHDHIVSTIY--------STFGAFYIP
LVLILILYYKIYRAARTLYHKRQASRMIKEehSTVKSPRSELkaATTLGLILGAFVICWLPFFVKELVVN
VCecKISEEMSNFLAWLGYLNSLINPLIYTIFNEDFKKAFQKLVRCR--------------
>143:P28564 5-hydroxytryptamine receptor 1B OS=Rattus norvegicus OX=10116 GN=Htr1b PE=2 SV=1 2 244 4e-77 1 79.8% 34.8% 50:328 63:384
-------------------------------------------------NAFVIATVYRTRKLHTPANYL
IASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASIMHLCVIALDRYWAITDAVDY
SAKRTPKRAAIMIVLVWVFSISISLPPFF-------WRQAKAEEEVLDCFVNTDHVLYTVYSTVGAFYLP
TLLLIALYGRIYVEARSRiqLITDSPGSTSSVTSINSraRERKATKTLGIILGAFIVCWLPFFIISLVMP
ICKDACWfaIFDFFNWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>144:P47747 Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1 2 242 8e-77 1 82.7% 32.4% 49:338 35:317
------------------------------------------------GNVVVCLAVGLNRRLRSLTNCF
IVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRY
PVLITPARVAISLVFIWVISITLSFLSIHLGWN--SRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLP
LLIMCITYFRIFKIAREQARRINHIGS------WKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRG
LKGDDAVNEVfdVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSL---
>145:O08892 5-hydroxytryptamine receptor 1B OS=Cavia porcellus OX=10141 GN=HTR1B PE=3 SV=1 2 243 1e-76 1 93.5% 32.5% 3:328 14:387
--LGSQTGLPHANVSAPPNNCSAPSHIylPWKVLLVVLLALITLATTLSNAFVIATVYRTRKLHTPANYL
IASLAFTDLLVSILVMPISTMYTVTGRWTLGQALCDFWLSSDITCCTASIMHLCVIALDRYWAITDAVGY
SAKRTPRRAAGMIALVWVFSICISLPPFF-------WRQAKAEEEVLDCLVNTDHVLYTVYSTGGAFYLP
TLLLIALYGRIYVEARSRiqLITDSPGSTSSVTSINSraRERKATKTLGVILGAFIVCWLPFFIISLVMP
ICKDACWfaIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>146:P49144 5-hydroxytryptamine receptor 1B OS=Oryctolagus cuniculus OX=9986 GN=HTR1B PE=2 SV=1 2 243 1e-76 1 79.8% 34.4% 50:328 67:388
-------------------------------------------------NAFVVATVYRTRKLHTPANYL
IASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDLWLSSDITCCTASIMHLCVIALDRYWAITDAVEY
SAKRTPKRAAIMIRLVWVFSICISLPPFF-------WRQAKAEEEVSECLVNTDHVLYTVYSTVGAFYLP
TLLLIALYGRIYVEARSRiqLITDSPGSTTSVTSINSraRERKATKTLGIILGVFIVCWLPFFIISLVMP
ICKDAchQAIFDFFTWLGYVNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>147:P34969 5-hydroxytryptamine receptor 7 OS=Homo sapiens OX=9606 GN=HTR7 PE=1 SV=2 2 245 2e-76 1 88.9% 31.4% 16:327 63:402
---------------PPDNASGCGEqyGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYL
IVSLALADLSVAVAVMPfsVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTY
PVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKV---------CLISQDFGYTIYSTAVAFYIP
MSVMLFMYYQIYKAARKSAAKHKfsRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARP
FicSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQ--------------
>148:P56496 5-hydroxytryptamine receptor 1B OS=Spalax ehrenbergi OX=30637 GN=HTR1B PE=3 SV=1 2 242 4e-76 1 79.8% 34.8% 50:328 63:384
-------------------------------------------------NAFVIATVYRTRKLHTPANYL
IASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASIMHLCVIALDRYWAITDAVEY
SAKRTPRRAAVMIALVWVFSISISLPRFF-------WRQAKAEEEVLDCLVNTDHVLYTVYSTVGAFYLP
TLLLIALYGRIYVEARSRiqLISDSPGSTSSVTSINSraRERKATKTLGIILGAFIVCWLPFFIISLVMP
ICKDACWfaIFDFFNWLGYLNSLINPIIYTMPNEDFKQAFHKLIRFKC-------------
>149:P30940 5-hydroxytryptamine receptor 1F OS=Rattus norvegicus OX=10116 GN=Htr1f PE=3 SV=1 2 241 4e-76 1 88.6% 28.3% 17:327 8:365
----------------DQNLTSEELLNRMPSKILVSLTLSGLALMTTTINCLVITAIIVTRKLHHPANYL
ICSLAVTDFLVAVLVMPFSIVYIVRESWIMGQGLCDLWLSVDIICCTCSILHLSAIALDRYRAITDAVEY
ARKRTPRHAGITITTVWVISVFISVPPLFWRHQGNSRDD---------QCIIKHDHIvtIYSTFGAFYIP
LVLILILYYKIYRAARTLYHKRQASRMIKEehSTVKSPRSELkaATTLGLILGAFVICWLPFFVKELVVN
ICecKISEEMSNFLAWLGYLNSLINPLIYTIFNEDFKKAFQKLVRCR--------------
>150:P46636 5-hydroxytryptamine receptor 1B OS=Cricetulus griseus OX=10029 GN=HTR1B PE=2 SV=1 2 240 1e-75 1 79.8% 34.4% 50:328 63:384
-------------------------------------------------NAFVIATVYRTRKLHTPANYL
IASLAVTDLLVSILVMPVSTMYTVTGRWTLGQVVCDFWLSSDITCCTASIMHLCVIALDRYWAITDAVEY
AAKRTPKRAAIMIALVWVFSISISLPPFF-------WRQAKAEEEVLTCLVNTDHVLYTVYSTGGAFYLP
TLLLIALYGRIYVEARSRiqLITDSPGSTTSVTSINSraRERKATKTLGIILGAFIVCWLPFFIISLVMP
ICKDACWfaTLDFFNWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKC-------------
>151:P32305 5-hydroxytryptamine receptor 7 OS=Rattus norvegicus OX=10116 GN=Htr7 PE=2 SV=2 2 242 1e-75 1 93.3% 29.1% 1:327 53:405
LEVTASPAPTWDAPPDNVSGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYL
IVSLALADLSVAVAVMPfsVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTY
PVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKV---------CLISQDFGYTIYSTAVAFYIP
MSVMLFMYYQIYKAARKSAAKHKfsRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARP
FicSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQ--------------
>152:P50407 5-hydroxytryptamine receptor 7 OS=Cavia porcellus OX=10141 GN=HTR7 PE=2 SV=1 2 242 2e-75 1 88.6% 30.5% 17:327 67:403
----------------NVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYL
IVSLALADLSVAVAVIPfsVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTY
PVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKV---------CLISQDFGYTIYSTAVAFYIP
MSVMLFMYYRIYKAARKSAAKHKfsRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARP
FIcsCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQ--------------
>153:Q9Y5X5 Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2 2 243 3e-75 1 96.2% 24.3% 9:341 123:467
--------DTKHHLYSDINITYVNYYLHQPQVAAIFIiyFLIFFLCMMGNTVVCFIVMRNKHMHTVTNLF
ILNLAISDLLVGIFCMPITLLDNIIAGWPFGNTMCKISGLVQGISVAASVFTLVAIAVDRFQCVVYPFK-
-PKLTIKTAFVIIMIIWVLAITIMSPSayYRVRLNSQNKTSPVYWCREDWPNqmRKIYTTVLFANIYLAP
LSLIVIMYGRIGI---SLFRAAVPHTGRKNQEQWHVVSRKKQKIIKMLLIVALLFILSWLPLWTLMMLSD
YADLSPNeyIYPFAHWLAFGNSSVNPIIYGFFNENFRRGFQEAFQLQLCQKRAKPMEAYAL
>154:P32304 5-hydroxytryptamine receptor 7 OS=Mus musculus OX=10090 GN=Htr7 PE=2 SV=2 2 241 3e-75 1 88.6% 30.5% 17:327 69:405
----------------NVSGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYL
IVSLALADLSVAVAVMPfsVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTY
PVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKV---------CLISQDFGYTIYSTAVAFYIP
MSVMLFMYYQIYKAARKSAAKHKFSGFPrhERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARP
FicSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQ--------------
>155:Q91559 5-hydroxytryptamine receptor 7 OS=Xenopus laevis OX=8355 GN=htr7 PE=2 SV=1 2 240 7e-75 1 84.8% 35.6% 30:327 68:398
-----------------------------TEKIVIGVVLSIITLFTIAGNALVIISVCIVKKLRQPSNYL
VVSLAAADLSVAVAVMPFVIItlVGGEWLFGKVFCNVFIAMDVMCCTASIMTLCVISVDRYLGITRPLTY
PARQNGKLMAKMVFIVWLLSASITLPPLFGWAKNVNVERV---------CLISQDFGYTVYSTAVAFYIP
MTVMLVMYQRIFVAAkeKHKFVNIPRLYEQEGIYcsIFKREQKAARTLGIIVGAFTFCWLPFFLLSTARP
FicSCMPLRLERTLLWLGYTNSLINPLIYAFFNRDLRTTFWNLLRCK--------------
>156:P13945 Beta-3 adrenergic receptor OS=Homo sapiens OX=9606 GN=ADRB3 PE=1 SV=3 2 239 9e-75 1 88.3% 34.9% 17:320 24:356
----------------TANTSGLPGVPWEAALAGALLALAVLATVG--GNLLVIVAIAWTPRLQTMTNVF
VTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRY
GALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAfsNMPYVLLSSSVSFYLP
LLVMLFVYARVFVVATRQLrpVGTCAPPEGVPACGRRParEHRALCTLGLIMGTFTLCWLPFFLANVLRA
LGGPsvPGPAFLALNWLGYANSAFNPLIY-CRSPDFRSAF---------------------
>157:Q5IS65 5-hydroxytryptamine receptor 6 OS=Pan troglodytes OX=9598 GN=HTR6 PE=2 SV=1 2 240 1e-74 1 93.5% 32.3% 16:340 7:350
---------------PSANSTPAWGAGPPSAPgwVAAALCVVIALTAAANSLLIALICTQPALRNTSNFF
LVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRY
KLRMTPPRALALVLGAWSLAALASFLPLLLGWHELGH----ARPPVPGQCRLLASLPFVLVASGLTFFLP
SGAICFTYCRILLAARKQAVQVASleSADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQA
VCDCISP-GLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCP-RCPRERQASLAS-
>158:P50406 5-hydroxytryptamine receptor 6 OS=Homo sapiens OX=9606 GN=HTR6 PE=1 SV=1 2 238 3e-74 1 93.5% 32.0% 16:340 7:350
---------------PTANSTPAWGAGPPSAPgwVAAALCVVIALTAAANSLLIALICTQPALRNTSNFF
LVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRY
KLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGH----ARPPVPGQCRLLASLPFVLVASGLTFFLP
SGAICFTYCRILLAARKQAVQVASleSADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQA
VCDCISP-GLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCP-RCPRERQASLAS-
>159:Q6VB83 5-hydroxytryptamine receptor 1E OS=Cavia porcellus OX=10141 GN=5HT1E PE=2 SV=1 2 235 1e-73 1 89.1% 29.3% 17:327 7:362
----------------TTDASMVVRPKTVTEKMLICMTLVIITTLTMLLNSAVIMAICTTKKLHQPANYL
ICSLAVTDLLVAVLVMPLSIMYIVMDSWRLGYFICEVWLSVDMTCCTCSILHLCVIALDRYWAITNAIEY
ARKRTAKRAGLMILTVWTISIFISMPPLFWRSHRQ-------LSPPPSQCTIQHDhiYTIYSTFGAFYIP
LTLILILYYRIYHAAKSLYQKRGSSRHLSNreRQQISSTRERKAARILGLILGAFILSWLPFFIKELIVG
LSIYTVSSEVGDFLTWLGYVNSLINPLLYTSFNEDFKLAFKKLIRCR--------------
>160:P11617 Adenosine receptor A2a OS=Canis lupus familiaris OX=9615 GN=ADORA2A PE=2 SV=1 2 235 2e-73 1 87.1% 27.9% 33:333 7:312
--------------------------------WVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYF
VVSLAAADIAVGVLAIPFAITISTGFCAACHN--CLFFACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRY
NGLVTGTRAKGIIAVCWVLSFAIGLTPMLGWNNCsnYSQGCGEGQVACLFEDVVPMNYMVYYNFFAFVlp
LLLMLGVYLRIFLAARRQLKQME--SQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTF
FCPECspLWLMYLTIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRRRE--------
>161:F1MV99 Somatostatin receptor type 5 OS=Bos taurus OX=9913 GN=SSTR5 PE=3 SV=2 2 234 2e-73 1 79.2% 27.7% 43:327 52:324
------------------------------------------CAVGLGGNTLVIYVVLRHAKMKTVTNIY
ILNLAVADVLLML-GLPFVATQNAISYWPFGPVLCRLVMTLDGINQFTSIFCLTVMSVDRYLAVVHPIRS
ARWRRPRVAKLASAAVWAFSLVMSLPLVVFADIQEGWNTCNLSWPEPVG---LWGAVFIIYTSVLGFFGP
LLVICLCYLLIVVKLKASGVRVGSTRRR-----------SERKVTRMVVVVVLVFAGCWLPFFIVNIVna
LPEEPASAGAYFFVVVLSYANSCANPLLYGFLSDNFRQSFRKVLCLR--------------
>162:P35346 Somatostatin receptor type 5 OS=Homo sapiens OX=9606 GN=SSTR5 PE=1 SV=3 2 234 2e-73 1 78.9% 26.3% 43:327 51:322
------------------------------------------CAAGLGGNTLVIYVVLRFAKMKTVTNIY
ILNLAVADVLYML-GLPFLATQNAASFWPFGPVLCRLVMTLDGVNQFTSVFCLTVMSVDRYLAVVHPLSS
ARWRRPRVAKLASAAAWVLSLCMSLPLLVFADVQEGGTCNASWPEPVG----LWGAVFIIYTAVLGFFAP
LLVICLCYLLIVVKVRAAGVRVGCVRRR-----------SERKVTRMVLVVVLVFAGCWLPFFTVNIVna
LPQEPASAGLYFFVVILSYANSCANPVLYGFLSDNFRQSFQKVLCLR--------------
>163:Q804Q2 Melanopsin-B OS=Gadus morhua OX=8049 GN=opn4b PE=2 SV=1 2 240 5e-73 1 84.5% 22.3% 34:329 20:317
---------------------------------VIAFFVLIIGVVGVTGNALVMYAFLCNKKLRTPPNYF
IMNLAVSDFLMAITQSPIFFINSLFKEWIFGETGCRMYAFCGALFGITSMINLLAISLDRYIVITKPPQA
IRWVSGRRTMVVILLVWLYSLAWSLAPLL------GWSSYIPEG-LMTSCTWDynKGYTLMLCCFVFFIP
LGIISYCYLCMFLAIRSAGREIERLGTQVRKSTLMQQqkTEWKLTKVAFVVIIVYVHSWSPYACVTLIAw
yGSHLSPYSK-AVPAVIAKASAIYNPFIYAIIHSKYRDTLAEHVPCLYF------------
>164:P46626 Beta-3 adrenergic receptor OS=Bos taurus OX=9913 GN=ADRB3 PE=2 SV=1 2 234 5e-73 1 91.8% 34.5% 17:332 24:368
----------------TANASGLPGVPWAVALAGALLALAVLATVG--GNLLVIVAIARTPRLQTMTNVF
VTSLATADLVVGLLVVPPGATLALTGHWPLGVTGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRY
GALVTKRRALAAVVLVWVVSAAVSFAPIMSKWWRIGAdeAQRCHSNPRCCTFASNMPYALLSSSVSFYLP
LLVMLFVYARVFVVATRQlcASPAGVPSYGRRPARLLPLREHRALRTLGLIMGTFTLCWLPFFVVNVVRA
LGGPSLVSgtFLALNWLGYANSAFNPLIY-CRSPDFRSAFRRLLCRCRPEEH---------
>165:Q9MYW9 Mu-type opioid receptor OS=Macaca mulatta OX=9544 GN=OPRM1 PE=2 SV=2 2 234 5e-73 1 90.6% 23.8% 2:324 33:353
-NLSHLDGNLSDPCGPNRTdcPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIY
IFNLALADALVT-STLPFQSVNYLMGTWPFGTILCKIVISIDYYNMSTSIFTLCTMSVDRYIAVCHPVKA
LDFRTPRNAKIINVCNWILSSAIGLPVMF-MATTKYRQGSIDCTLTFSHPSWYWENLLKICVFIFAFIMP
VLIITVCYGLMILRLKSVRMLSGSKEKDRNL----------RRITRMVLVVVAVFIICWTPIHIYVIIKA
LV--TIPETTFQTVSwlGYTNSCLNPVLYAFLDEDFKRCFREFC-----------------
>166:Q9R1C8 5-hydroxytryptamine receptor 6 OS=Mus musculus OX=10090 GN=Htr6 PE=1 SV=1 2 235 9e-73 1 85.9% 32.9% 35:332 29:345
----------------------------------VAAALCVVIVLTAAANSLLIALICTQPALRNTSNFF
LVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRY
KLRMTAPRALALILGAWSLAALASFLPLLLGWHELGKARTSAP----GQCRLLASLPYVLVASGVTFFLP
SGAICFTYCRILLAARKQAVQVAsmESADSRRLTTKHSRKALKASLTLGILLSMFFVTWLPFFVASIAQA
VCDCISP-GLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFVPCVHCPPE---------
>167:Q5XXP2 Melanopsin OS=Phodopus sungorus OX=10044 GN=OPN4 PE=2 SV=1 2 235 1e-72 1 84.8% 23.5% 34:326 71:363
---------------------------------ILGTVILLVGLTGMLGNLTVIYTFCRSRSLRTPANML
IINLAVSDFLMSFTQAPVFFASSLYKKWLFGETGCEFYAFCGAVLGITSMITLTAIALDRYLVITRPLAT
IGMGSKRRTALVLLGIWLYALAWSLPPFFGwyVPEGLLTSCSWDYVTFTPQV---RAYTMLLFCFVFFLP
LLVIIFCYISIFRAIRETGRACEGWSESPQRRRQWHRLQSEWKMAKVALIVILLFVLSWAPYSTVALvaG
YSHILTPY-MSSVPAVIAKASAIHNPIVYAITHPKYRAAIAQHLPC---------------
>168:Q5YKK9 Melanopsin OS=Felis catus OX=9685 GN=OPN4 PE=2 SV=1 2 235 1e-72 1 84.5% 22.9% 35:326 68:362
----------------------------------LGTVILLVGLTGILGNLMVIYTFCRSRGLRTPANMF
IINLAVSDFFMSFTQAPVFFASSLHKRWLFGEAGCEFYAFCGALFGITSMITLMAIALDRYLVITHPLAT
IGVVSKRRAALVLLGVWLYALAWSLPPFFGwyVPEGLLTSCSWDYMSFTPSV---RAYTMLLFCFVFFLP
LLVIVYCYIFIFRAIRETGQALQTFRACEgsPRQRQRLQREWKMAKIELLVILLFVLSWAPYSIVALmaG
YAHVLTPY-MNSVPAVIAKASAIHNPIIYAITHPKYRMAIAQHLPC---------------
>169:O57422 Melanopsin-B OS=Xenopus laevis OX=8355 GN=opn4b PE=2 SV=1 2 237 1e-72 1 89.4% 19.9% 35:341 30:338
----------------------------------IGSFILIIGSVGIIGNMLVLYAFYRNKKLRTAPNYF
IINLAISDFLMSATQAPVCFLSSLHREWILGDIGCNVYAFCGALFGITSMMTLLAISINRYIVITKPLQS
IQWSSKKRTSQIIVLVWMYSLMWSLAPLLGWSSYVPEGLRISCTWDYVTSTMS-NRSYTMMLCCCVFFIP
LIVISHCYLFMFLAIRSTGRNVQKLGSYGRQSFLSQSMKNEWKMAKIAFVIIIVFVLSWSPYACVTLIAw
hGKSLTPYSK-TVPAVIAKASAIYNPIIYGIIHPKYRETIHKTVPCLRfrEPKKDIFESSV
>170:P29274 Adenosine receptor A2a OS=Homo sapiens OX=9606 GN=ADORA2A PE=1 SV=2 2 233 1e-72 1 85.9% 29.5% 33:330 7:309
--------------------------------SVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYF
VVSLAAADIAVGVLAIPFAITISTGFC--AACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRY
NGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNceGKNHSQGCGEGQVAC-LFEDVVPMNYMVYFNFfvP
LLLMLGVYLRIFLAARRQLKQME--SQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTF
FCPDCspLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLR-----------
>171:Q6TLI7 Adenosine receptor A2a OS=Equus caballus OX=9796 GN=ADORA2A PE=2 SV=1 2 232 3e-72 1 86.8% 27.7% 34:333 8:312
---------------------------------VYIMVELAIALLAILGNMLVCWAVWLNSNLQNVTNYF
VVSLAAADIAVGVLAIPFAITISTGFC--AACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRY
NGLVTGTRAKGVIAVCWVLSFAIGLTPMLGWNNCHHwsQGCGEGQVACLFEDVVPMNYMVYYNFFACVlp
LLLMLGVYLRIFLAARRQLKQMET--QPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTF
FCPECppLWLMYPAIILSHFNSVVNPFIYAYRIREFRHTFHKIIRSHILRRQE--------
>172:Q95M54 Mu-type opioid receptor OS=Macaca fascicularis OX=9541 GN=OPRM1 PE=2 SV=1 2 232 4e-72 1 91.2% 22.6% 2:324 33:353
-NLSHLDGNLSDPCGPNRTdcPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIY
IFNLALADALVT-STLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKA
LDFRTPRNAKIINVCNWILSSAIGLPVMF-MATTKYRQGSIDCTLTFSHPSWYWENLLKICVFIFAFIMP
VLIITVCYGLMILRLKSVRMLSGSKEKDRNL----------RRITRMVLVVVAVFIICWTPIHIYVIIKA
LveTTLQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFC-----------------
>173:P28646 Somatostatin receptor type 1 OS=Rattus norvegicus OX=10116 GN=Sstr1 PE=2 SV=1 2 231 7e-72 1 83.3% 26.4% 31:326 57:340
------------------------------SAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIY
ILNLAIADELLMLSV-PFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKA
ARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLP
VGAICLCYVLI--IAKMRMVALKAGWQQRKR--------SERKITLMVMMVVMVFVICWMPFYVVQLVNV
FAE-QDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCL---------------
>174:Q4R1I4 Melanopsin OS=Branchiostoma belcheri OX=7741 GN=OPN4 PE=1 SV=1 2 239 7e-72 1 91.8% 23.0% 10:326 57:385
---------PTPGCTGNgnGTDSGGVVWDIPPLAHYIVGTAVFCIgmFGNAVVVYSFIKSKGLRTPANFF
IINLALSDFLMNLTNMPIFAVNSAFQRWLLSDFACELYGFAGGLFGCLSINTLMAISMDRYLVITKPFLV
MRIVTKQRVMFAILLLWIWSLVWALPPLFGWSAyeGFGTSCTFDYMTPKLSYH---IFTYIIFFTMYFIP
GGVMIYCYYNIFATVKSGDKQFGKAVKekNKAQQERQRKNEIKTAKIAFIVISLFMSAWTPYAVVSALGt
yQDLVTPY-LQSIPAMFAKSSAVYSPIVYAITYPKFREAVKKHIPC---------------
>175:Q5R4Q6 5-hydroxytryptamine receptor 2A OS=Pongo pygmaeus OX=9600 GN=HTR2A PE=2 SV=1 2 233 8e-72 1 93.5% 28.7% 14:341 57:411
-------------CEGCLSPSCL-SLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYF
LMSLAIADMLLGFLVMPVSMLTILYGywPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHH
SRFNSRTKAFLKIIAVWTISVGISMPI-----PVFGLQD-DSKVFKEGSCLLADDNF-VLIGSFVSFFIP
LTIMVITYFLTIKSLQKEarSIHREPGSYTGRRTMQSISNEQKACKVLGIVFSLFVVMWCPFFITNIMAV
ICKESciGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQ-YKENKKPLQLILV
>176:P30873 Somatostatin receptor type 1 OS=Mus musculus OX=10090 GN=Sstr1 PE=1 SV=1 2 230 1e-71 1 83.3% 26.4% 31:326 57:340
------------------------------SAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIY
ILNLAIADELLMLSV-PFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKA
ARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLP
VGAICLCYVLI--IAKMRMVALKAGWQQRKR--------SERKITLMVMMVVMVFVICWMPFYVVQLVNV
FAE-QDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCL---------------
>177:P28223 5-hydroxytryptamine receptor 2A OS=Homo sapiens OX=9606 GN=HTR2A PE=1 SV=2 2 232 1e-71 1 93.5% 28.7% 14:341 57:411
-------------CEGCLSPSCL-SLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYF
LMSLAIADMLLGFLVMPVSMLTILYGywPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHH
SRFNSRTKAFLKIIAVWTISVGISMPI-----PVFGLQD-DSKVFKEGSCLLADDNF-VLIGSFVSFFIP
LTIMVITYFLTIKSLQKEarSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAV
ICKESciGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQ-YKENKKPLQLILV
>178:P50128 5-hydroxytryptamine receptor 2A OS=Macaca mulatta OX=9544 GN=HTR2A PE=2 SV=1 2 232 1e-71 1 93.5% 28.7% 14:341 57:411
-------------CEGCLSPSCL-SLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYF
LMSLAIADMLLGFLVMPVSMLTILYGywPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHH
SRFNSRTKAFLKIIAVWTISVGISMPI-----PVFGLQD-DSKVFKEGSCLLADDNF-VLIGSFVSFFIP
LTIMVITYFLTIKSLQKEarSIHRDPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAV
ICKESciGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQ-YKENKKPLQLILV
>179:O15973 Rhodopsin, GQ-coupled OS=Mizuhopecten yessoensis OX=6573 GN=SCOP1 PE=1 SV=1 2 233 2e-71 1 87.4% 22.9% 34:334 53:361
---------------------------------IIGVYITIVGLLGIMGNTTVVYIFSNTKSLRSPSNLF
VVNLAVSDLIFSAvgFPLLTVSSFHQKWIFGSLFCQLYGFVGGVFGLMSINTLTAISIDRYVVITKPLQA
SQTMTRRKVHLMIVIVWVLSILLSIPPFFGWgiPEGFQTSCTFDYLTKT---ARTRTYIVVLYLFGFLIP
LIIIGVCYVLIIRGVRRHDQkiTRSMKTEDARANNKRARSELRISKIAMTVTCLFIISWSPYAIIALIAQ
fpAHWITPLVSELPMMLAKSSSMHNPVVYALSHPKFRKALYqlFCCCKPKEKAD-------
>180:P31388 5-hydroxytryptamine receptor 6 OS=Rattus norvegicus OX=10116 GN=Htr6 PE=1 SV=2 2 231 2e-71 1 85.9% 32.6% 35:332 29:343
----------------------------------VAAALCVVIVLTAAANSLLIVLICTQPALRNTSNFF
LVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRY
KLRMTAPRALALILGAWSLAALASFLPLLLGWHELGKARTPAP----GQCRLLASLPFVLVASGVTFFLP
SGAICFTYCRILLAARKQAVQVAsmESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIAQA
VCDCISP-GLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCVHCPPE---------
>181:Q6XL69 Melanopsin OS=Rutilus rutilus OX=48668 GN=opn4 PE=2 SV=1 2 232 2e-71 1 83.9% 24.1% 34:324 66:355
---------------------------------IIGAVILIVGITGVIGNALVIYVFCRSRTLRTAGNMF
VVNLAVADFFMSLTQSPVFFAASLHRRWIFGERICELYAFCGALFGICSMMTLTAIAADRCLAITQPLAL
VGNVSRRKAGAVLAVVWLYSLGWSLPPFFGwyVPEGLQTSCSWDYMTFTPSV---RAYTILLFIFVFFIP
LGIIVSCYVGIFQAIRAMGKEIRELDCGETQKVYER-MQNEWKMAKIALLVILLFVISWSPYSVVALTAt
ySHLLTPY-MNSVPAVIAKASAIHNPIIYAITHPKYRAAIARYI-----------------
>182:P28566 5-hydroxytryptamine receptor 1E OS=Homo sapiens OX=9606 GN=HTR1E PE=1 SV=1 2 228 3e-71 1 78.6% 30.9% 53:327 43:362
----------------------------------------------------VIMAIGTTKKLHQPANYL
ICSLAVTDLLVAVLVMPLSIIYIVMDRWKLGYFLCEVWLSVDMTCCTCSILHLCVIALDRYWAITNAIEY
ARKRTAKRAALMILTVWTISIFISMPPLF-------WRSHRRLSPPPSQCTIQHDhiYTIYSTLGAFYIP
LTLILILYYRIYHAAKSLYQKRGSSRHLSNreRQQISSTRERKAARILGLILGAFILSWLPFFIKELIVG
LSIYTVSSEVADFLTWLGYVNSLINPLLYTSFNEDFKLAFKKLIRCR--------------
>183:Q1JPS6 Melanopsin-like OS=Danio rerio OX=7955 GN=opn4l PE=2 SV=1 2 232 4e-71 1 83.9% 24.1% 34:324 66:355
---------------------------------IIGSVILIVGITGVIGNALVVYVFCRSRTLRTAGNMF
IVNLAVADFLMSVTQSPVFFAASLHRRWVFGERPCELYAFCGALFGICSMMTLTAIAADRCLAITQPLAL
VSRVSRRKAGAVLVVVWLYSLGWSLPPFFGwyVPEGLQTSCSWDYMTFTPSV---RAYTILLFVFVFFIP
LGIIGSCYFAIFQTIRAAGKEIRELDCGETHKVYER-MQNEWKMAKVALVVIVLFIISWSPYSVVALTAt
ySHFLTPY-MNSVPAVIAKASAIHNPIIYAITHPKYRVAIARYI-----------------
>184:Q9N2B6 5-hydroxytryptamine receptor 1E (Fragment) OS=Pan troglodytes OX=9598 GN=HTR1E PE=3 SV=1 2 228 4e-71 1 78.6% 30.9% 53:327 43:362
----------------------------------------------------VIMAIGTTKKLHQPANYL
ICSLAVTDLLVAVLVMPLSIIYIVMDRWKLGYFLCEVWLSVDMTCCTCSILHLCVIALDRYWAITNAIEY
ARKRTAKRAALMILTVWTISIFISMPPLF-------WRSHRRLSPPPSQCTIQHDhiYTIYSTLGAFYIP
LTLILILYYRIYHAAKSLYQKRGSSRHLSNreRQQISSTRERKAARILGLILGAFILSWLPFFIKELIVG
LSIYTVSSEVADFLTWLGYVNSLINPLLYTSFNEDFKLAFKKLIRCR--------------
>185:Q804X9 Melanopsin-A OS=Gadus morhua OX=8049 GN=opn4a PE=2 SV=1 2 233 6e-71 1 86.5% 21.7% 35:333 33:334
----------------------------------VAFFVSVIGTLGVTGNALVQFAFYSNKKLRNLPNYF
IMNQAASDFLMAFTQSPFFFINCLNREWIFGELGCKLYAFLGALFGITSMINLLAISLDRYMVITRPLEA
MKWNSKRRTTIAILLVWLYSLAWSLAPLVGWSspEGLRTSCTWDYVT---YTASNRSYTMMLCCFVFFIP
LAIISYCYLFMFLAIRKTSRDVERLGIQVRKSTIIRQkrTEWKLAKIAFVVIVVYVLSWSPYACVTMISw
hANILSPYSK-TVPAVIAKASTIYNPFIYAIIHQKYRKTLakVPCLRFLAPNK--------
>186:P50129 5-hydroxytryptamine receptor 2A OS=Sus scrofa OX=9823 GN=HTR2A PE=2 SV=1 2 230 7e-71 1 93.5% 27.4% 14:341 57:410
-------------CEGCLSPPCF-SLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYF
LMSLAIADMLLGFLVMPVSMLTILYGywPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHH
RRFNSRTKAFLKIIAVWTISVGISMPI-----PVFGLQD-DSKVFKEGSCLLADDNF-VLIGSFVSFFIP
LTIMVITYFLTIKSLqkLFQRSIHREPGSYGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAV
ICKESciGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQ-YKENKKPLQLILV
>187:P42866 Mu-type opioid receptor OS=Mus musculus OX=10090 GN=Oprm1 PE=1 SV=1 2 229 7e-71 1 90.3% 25.3% 1:324 30:351
LNLSHVDGNQSDPCGP--NRTGLGGSHSLCPQttIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIY
IFNLALADAL-ATSTLPFQSVNYLMGTWPFGNILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKA
LDFRTPRNAKIVNVCNWILSSAIGLPVMF-MATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMP
VLIITVCYGLMILRLKSVRMLSGSKEKDRNL----------RRITRMVLVVVAVFIVCWTPIHIYVIIKA
LI--TIPETTFQTVSwlGYTNSCLNPVLYAFLDENFKRCFREFC-----------------
>188:O46635 5-hydroxytryptamine receptor 2A OS=Canis lupus familiaris OX=9615 GN=HTR2A PE=2 SV=2 2 230 9e-71 1 93.5% 27.4% 14:341 57:410
-------------CEGCLSPPCF-SLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYF
LMSLAIADMLLGFLVMPVSMLTILYGywPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHH
SRFNSRTKAFLKIIAVWTISVGISMPI-----PVFGLQD-DSKVFKEGSCLLADDNF-VLIGSFVSFFIP
LTIMVITYFLTIKSLqkLFQRSIHREPGSYGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAV
ICKESciGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQ-YKENKKPLQLILV
>189:O02836 Neuropeptide Y receptor type 2 OS=Sus scrofa OX=9823 GN=NPY2R PE=2 SV=2 2 227 1e-70 1 89.7% 23.3% 10:326 29:343
---------PRGELAPDSEPELKDSTKLIEVQIILILAYCSIILLGVVGNSLVIHVVIKFKSMRTVTNFF
IANLAVADLLVNTLCLPFTLTYTLMGEWKMGPVLCHLVPYAQGLAVQVSTITLTVIALDRHRCIVYHLE-
-SKISKRISFLIIGLAWGISALLASPliFREYSLIEIIPDFEIVACTEKWpsIYGTVYSLSSLLILYVLP
LGIISFSYARIWSKLKNHV---------SPGGVNDHYHQRRQKTTKMLVCVVVVFAVSWLPLHAFQLasQ
VLDLKEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRC---------------
>190:P30937 Somatostatin receptor type 4 OS=Rattus norvegicus OX=10116 GN=Sstr4 PE=1 SV=1 2 227 2e-70 1 83.0% 26.3% 33:329 44:327
--------------------------------VTIQCIYALVCLVGLVGNALVIFVILRYAKMKTATNIY
LLNLAVADELFMLSV-PFVASAAALRHWPFGAVLCRAVLSVDGLNMFTSVFCLTVLSVDRYVAVVHPLRA
ATYRRPSVAKLINLGVWLASLLVTLPIAVFADTRPA--RGGEAVACNLHWPHpwSAVFVIYTFLLGFLLP
VLAIGLCYLLI--VGKMRAVALRAGWQQRRR--------SEKKITRLVLMVVTVFVLCWMPFYVVQLLNL
FVT-SLDATVNHVSLILSYANSCANPILYGFLSDNFRRSFQRVLCLRCC------------
>191:Q9TUP7 Orexin receptor type 2 OS=Canis lupus familiaris OX=9615 GN=HCRTR2 PE=1 SV=1 2 229 2e-70 1 89.1% 24.5% 27:332 49:387
--------------------------HPKEYEWVLIAGYIIVFVVALVGNVLVCVAVWKNHHMRTVTNYF
IVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMF
KS--TAKRARNSIVIIWIVSCIIMIPQAIVMECSTMLPGLANKTTLFTVCDERwpKMYHICFFLVTYMAP
LCLMVLAYLQIFrvVQRKWKPLQPASQPRGPGQqiKQIRARRKTARMLMVVLLVFAICYLPISILNVLKR
VfdRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVH---------
>192:P41144 Kappa-type opioid receptor OS=Cavia porcellus OX=10141 GN=OPRK1 PE=2 SV=1 2 226 3e-70 1 83.0% 23.5% 28:321 55:342
---------------------------SPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIY
IFNLALADALVT-TTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKA
LDFRTPLKAKIINICIWLLSSSVGISAIILGGTKVREDVDicSLQFPDDDYSWWDLFMKICVFVFAFVIP
VLIIIVCYTLMILRLKSVRLLSGSREKDRNL----------RRITRLVLVVVAVFIICWTPIHIFILVEA
LGSTSHSTAayYFCIALGYTNSSLNPILYAFLDENFKRCFR--------------------
>193:Q924H0 Neuropeptide FF receptor 2 OS=Mus musculus OX=10090 GN=Npffr2 PE=2 SV=2 2 227 3e-70 1 95.3% 22.5% 9:341 21:362
--------DTQHHWYSDINITYVNYYLHQPQVAAVFIsyLLIFVLCMVGNTVVCFIVIRNRHMHTVTNFF
ILNLAISDLLVGIFCMPITLLDNIIAGWPFGSSMCKISGLVQGISVAASVFTLVAIAVDRFRCVVYPFK-
-PKLTVKTAFVTIVIIWGLAIAIMTPSayYRVRLSSHNKTSTVYWCREDWPRhmRRIYTTVLFATIYLAP
LSLIVIMYARI----GASLFKTAAHCTGKQRPVQWHVSKKKQKVIKMLLTVALLFILSWLPLWTLMMLSD
YTDLSPNkyIYPFAHWLAFCNSSVNPIIYGFFNENFRNGFQDAF--QICQKKAKPQEAYSL
>194:Q9EQD2 Neuropeptide FF receptor 2 OS=Rattus norvegicus OX=10116 GN=Npffr2 PE=2 SV=1 2 227 3e-70 1 94.1% 22.9% 9:335 21:358
--------DTQHPWYSDINITYMNYYLHQPHVTAVFIsyFLIFFLCMVGNTVVCFVVIRNRYMHTVTNFF
IFNLAISDLLVGIFCMPITLLDNIIAGWPFGSSMCKISGLVQGISVAASVFTLVAIAVDRFRCVVYPFK-
-PKLTVKTAFVMIVIIWGLAITIMTPSayYRVRLSSHNKTSTVYWCREDWPNqmRRIYTTVLFATIYLAP
LSLIVIMYARI----GASLFKTSAHSTGKQRLEQWHVSKKKQKVIKMLLTVALLFILSWLPLWTLMMLSD
YADLSPNkyVYPFAHWLAFCNSSVNPIIYGFFNENFRSGFQDAFQFCQKKVKPQE------
>195:P18599 5-hydroxytryptamine receptor 2A OS=Cricetulus griseus OX=10029 GN=HTR2A PE=2 SV=1 2 229 3e-70 1 95.6% 27.2% 8:341 50:411
-------ENRTNLSFEGYLPPTCLSILHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYF
LMSLAIADMLLGFLVMPVSMLTILYGywPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHH
SRFNSRTKAFLKIIAVWTISVGVSMPI-----PVFGLQD-DSKVFKQGSCLLADDNF-VLIGSFVAFFIP
LTIMVITYFLTIKSLQKEarSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAV
ICKESciGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQ-YKENRKPLQLILV
>196:P28565 5-hydroxytryptamine receptor 1D OS=Rattus norvegicus OX=10116 GN=Htr1d PE=2 SV=1 2 226 4e-70 1 93.8% 32.1% 1:327 3:371
LPNQSLEGLPQEASNRSLNATGAWDPEVlaLRISLVVVLSIITLATVLSNAFVLTTILLTKKLHTPANYL
IGSLATTDLLVSILVMPISIAYTTTRTWNFGQILCDIWVSSDITCCTASILHLCVIALDRYWAITDALEY
SKRRTAGHAAAMIAAVWAISICISIPPLF-------WRQATAHEEMSDCLVNTSQISYTIYSTCGAFYIP
SILLIILYGRIYVAARSRicSLNPSLHESHTHTVGSPLfrERKATKTLGIILGAFIICWLPFFVVSLVLP
ICRDSchPALFDFFTWLGYLNSLINPVIYTVFNEDFRQAFQRVVHFR--------------
>197:P33535 Mu-type opioid receptor OS=Rattus norvegicus OX=10116 GN=Oprm1 PE=1 SV=1 2 227 4e-70 1 90.9% 24.7% 1:324 30:351
LNLSHVDGNQSDPCGLngNDSLCPQTGSPSMVTAITilYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIY
IFNLALADAL-ATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKA
LDFRTPRNAKIVNVCNWILSSAIGLPVMF-MATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMP
VLIITVCYGLMILRLKSVRMLSGSKEKDRNL----------RRITRMVLVVVAVFIVCWTPIHIYVIIKA
LI--TIPETTFQTVSwlGYTNSCLNPVLYAFLDENFKRCFREFC-----------------
>198:P30974 Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2 2 230 4e-70 1 85.6% 22.0% 29:328 80:382
----------------------------WEQKTIWAIIFGLMMFVAIAGNGIVLWIVTGHRSMRTVTNYF
LLNLSIADLLMSSLNCVFNFIFMLNSDWPFGSIYCTINNFVANVTVSTSVFTLVAISFDRYIAIVHPLK-
-RRTSRRKVRIILVLIWALSCVLSAPciMTKHYYNGKSRTVCFMMWPDgpTSMADYAYNLIILVLTYGIP
MIVMLICYSLMGRVLW------GSRSIGENTDRQMESMKSKRKVVRMFIAIVSIFAICWLPYHLFFIynQ
VASTKYVQHMYLGFYWLAMSNAMVNPLIYYWMNKRFRMYFQRIICCCC-------------
>199:Q49LX5 Somatostatin receptor type 1 OS=Canis lupus familiaris OX=9615 GN=SSTR1 PE=3 SV=1 2 226 4e-70 1 83.3% 26.4% 31:326 56:339
------------------------------SAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIY
ILNLAIADELLMLSV-PFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKA
ARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLP
VGAICLCYVLI--IAKMRMVALKAGWQQRKR--------SERKITLMVMMVVMVFVICWMPFYVVQLVNV
FAE-QDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCL---------------
>200:P30872 Somatostatin receptor type 1 OS=Homo sapiens OX=9606 GN=SSTR1 PE=1 SV=1 2 226 5e-70 1 83.3% 26.4% 31:326 57:340
------------------------------SAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIY
ILNLAIADELLMLSV-PFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKA
ARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLP
VGAICLCYVLI--IAKMRMVALKAGWQQRKR--------SERKITLMVMMVVMVFVICWMPFYVVQLVNV
FAE-QDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCL---------------
>201:Q75Z89 5-hydroxytryptamine receptor 2A OS=Bos taurus OX=9913 GN=HTR2A PE=2 SV=1 2 229 5e-70 1 93.5% 26.8% 14:341 57:410
-------------CEGCLSPPCF-SLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYF
LMSLAIADMLLGFLVMPVSTLTILYGywPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHH
SRFNSRTKAFLKIIAVWTISVGISMPI-----PVFGLQDD--SKVFKEGSCLLADENFVLIGSFVAFFIP
LTIMVITYFLTIKSLQKEATLCVSDPGTRTkrRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAV
ICKESciEALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQ-YKENKKPLQLILV
>202:Q9Z2D5 Neuropeptide Y receptor type 2 OS=Cavia porcellus OX=10141 GN=NPY2R PE=3 SV=1 2 226 5e-70 1 90.0% 22.6% 10:327 29:344
---------PRGELAPDPEPELIDSTKLTEVRVVLILAYCSIILLGVVGNSLVIHVVIKFKSMRTVTNFF
IANLAVADLLVNTLCLPFTLTYTLMGEWKMGPVLCHLVPYAQGLAVQVSTVTLTVIALDRHRCIVYHL--
DSKISKQNSFLIIGLAWGISALLASPliFREYSLIEIIPDFEIVACTEKWpsIYGTVYSLSSLLILYVLP
LGIISVSYVRIWSKLKNHVSPGAANDHYHQ---------RRQKTTKMLVFVVVVFAVSWLPLHAFQLasQ
VLDLKEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRCQ--------------
>203:Q5IS84 Mu-type opioid receptor OS=Saimiri boliviensis boliviensis OX=39432 GN=OPRM1 PE=2 SV=1 2 226 5e-70 1 90.6% 24.1% 2:324 33:353
-NLSHLDGNLSDPCGPnsDSPCPpgSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIY
IFNLALADAL-ATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKA
LDFRTPRNAKIVNVCNWIISSAIGLPVMF-MATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMP
VLIITVCYGLMILRLKSVRMLSGSKEKDRNL----------RRITRMVLVVVAVFIVCWTPIHIYVIIKA
LV--TIPETTFQTVSwlGYTNSCLNPVLYAFLDENFKRCFREFC-----------------
>204:O62809 Orexin receptor type 2 OS=Sus scrofa OX=9823 GN=HCRTR2 PE=2 SV=2 2 227 6e-70 1 89.1% 24.2% 27:332 49:387
--------------------------HPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYF
IVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMF
KS--TAKRARNSIVIIWIVSCIIMIPQAIVMECSTMLPGLANKTTLFTVCDERwpKMYHICFFLVTYMAP
LCLMVLAYLQIFrvVQRKWKPLQPVSQPRGPGQqiKQIRARRKTARMLMVVLLVFAICYLPISILNVLKR
VfdRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVH---------
>205:O43614 Orexin receptor type 2 OS=Homo sapiens OX=9606 GN=HCRTR2 PE=1 SV=2 2 227 1e-69 1 89.1% 24.5% 27:332 49:387
--------------------------HPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYF
IVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMF
KS--TAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERwpKMYHICFFLVTYMAP
LCLMVLAYLQIFrvVQRKWKPLQPVSQPRGPGQPTKSRMsrRKTARMLMIVLLVFAICYLPISILNVLKR
VfdRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVH---------
>206:Q61224 5-hydroxytryptamine receptor 1D OS=Mus musculus OX=10090 GN=Htr1d PE=2 SV=2 2 224 2e-69 1 93.3% 32.3% 3:327 5:371
--NQSLEGLPQEASNRSLNVTGAWDPEVlaLRISLVVVLSVITLATVLSNAFVLTTILLTKKLHTPANYL
IGSLATTDLLVSILVMPISIAYTTTRTWNFGQILCDIWVSSDITCCTASILHLCVIALDRYWAITDALEY
SKRRTAGHAAAMIAAVWIISICISIPPLF-------WRQATAHEEMSDCLVNTSQISYTIYSTCGAFYIP
SILLIILYGRIYVAARSRicSLNPSLHESHTHTVGSPLfrERKATKTLGIILGAFIICWLPFFVVSLVLP
ICRDSchPALFDFFTWLGYLNSLINPVIYTVFNEDFRQAFQKVVHFR--------------
>207:P56719 Orexin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Hcrtr2 PE=2 SV=1 2 227 2e-69 1 88.0% 24.5% 27:328 49:383
--------------------------HPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYF
IVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMF
KS--TAKRARNSIVVIWIVSCIIMIPQAIVMERSSMLPGLANKTTLFTVCDERwpKMYHICFFLVTYMAP
LCLMVLAYLQIFrvVQRKWKQPQPVSQPRGSGQqiKQIRARRKTARMLMVVLLVFAICYLPISILNVlrV
FGMFttVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCL-------------
>208:P49146 Neuropeptide Y receptor type 2 OS=Homo sapiens OX=9606 GN=NPY2R PE=1 SV=1 2 224 2e-69 1 92.1% 22.5% 2:326 20:342
-EQYGPQTTPRGELVPDPEPELIDSTKLIEVQVVLILAYCSIILLGVIGNSLVIHVVIKFKSMRTVTNFF
IANLAVADLLVNTLCLPFTLTYTLMGEWKMGPVLCHLVPYAQGLAVQVSTITLTVIALDRHRCIVYHLE-
-SKISKRISFLIIGLAWGISALLASPliFREYSLIEIIPDFEIVACTEKWpsIYGTVYSLSSLLILYVLP
LGIISFSYTRIWSKLKNHVSPGAANDHYHQ---------RRQKTTKMLVCVVVVFAVSWLPLHAFQLasQ
VLDLKEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRC---------------
>209:Q5IS62 Neuropeptide Y receptor type 2 OS=Pan troglodytes OX=9598 GN=NPY2R PE=2 SV=1 2 224 2e-69 1 92.1% 22.5% 2:326 20:342
-EQYGPQTTPRGELVPDPEPELIDSTKLIEVQVVLILAYCSIILLGVIGNSLVIHVVIKFKSMRTVTNFF
IANLAVADLLVNTLCLPFTLTYTLMGEWKMGPVLCHLVPYAQGLAVQVSTITLTVIALDRHRCIVYHLE-
-SKISKRISFLIIGLAWGISALLASPliFREYSLIEIIPDFEIVACTEKWpsIYGTVYSLSSLLILYVLP
LGIISFSYTRIWSKLKNHVSPGAANDHYHQ---------RRQKTTKMLVCVVVVFAVSWLPLHAFQLasQ
VLDLKEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRC---------------
>210:P79748 5-hydroxytryptamine receptor 1D OS=Takifugu rubripes OX=31033 GN=htr1d PE=3 SV=1 2 224 2e-69 1 93.8% 32.7% 1:327 3:378
LDNNSLDYFSSNFTDIPSNTTVAHWTEalGLQISVSVVLAIVTLATMLSNAFVIATIFLTRKLHTPANFL
IGSLAVTDMLVSILVMPISIVYTVSKTWSLGQIVCDIWLSSDITFCTASILHLCVIALDRYWAITDALEY
SKRRTMRRAAVMVAVVWVISISISMPPLF-WRQAKAHEELKECMVNTDQIS------YTLYSTFGAFYVP
TVLLIILYgrIFKTPSYSGKRFTTAQLIQTseRKRLCAARERKATKTLGIILGAFIICWLPFFVVTLVWA
IceCSFDPLLFDVFTWLGYLNSLINPVIYTVFNDEFKQAFQKLIKFR--------------
>211:P97295 Neuropeptide Y receptor type 2 OS=Mus musculus OX=10090 GN=Npy2r PE=2 SV=2 2 224 2e-69 1 89.7% 22.7% 10:326 28:342
---------PRGELPPDPEPELIDSTKLVEVQVILILAYCSIILLGVVGNSLVIHVVIKFKSMRTVTNFF
IANLAVADLLVNTLCLPFTLTYTLMGEWKMGPVLCHLVPYAQGLAVQVSTITLTVIALDRHRCIVYHLE-
-SKISKRISFLIIGLAWGISALLASPliFREYSLIEIIPDFEIVACTEKWpsVYGTVYSLSTLLILYVLP
LGIISFSYTRIWSKLRNHVSPGAASDHYHQ---------RRHKMTKMLVCVVVVFAVSWLPLHAFQLasH
VLDLKEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRC---------------
>212:P58308 Orexin receptor type 2 OS=Mus musculus OX=10090 GN=Hcrtr2 PE=2 SV=2 2 227 2e-69 1 88.0% 23.8% 27:328 49:383
--------------------------HPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYF
IVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMF
KS--TAKRARNSIVVIWIVSCIIMIPQAIVMECSSMLPGLANKTTLFTVCDEHwpKMYHICFFLVTYMAP
LCLMILAYLQIFrvVQRKWKQQQPVSQPRGSGQqiKQIRARRKTARMLMVVLLVFAICYLPISILNVLKR
VfdRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCL-------------
>213:Q16950 5-hydroxytryptamine receptor 1 OS=Aplysia californica OX=6500 GN=5HTB1 PE=2 SV=1 2 226 2e-69 1 89.4% 30.5% 33:337 37:379
--------------------------------VLIGIVGSLIITVAVVGNVLVCLAIFTEPIlhSKSNFF
IVSLAVADLLLALLVMTFALVNDMYGYWLFGETFCFIWMSADVMCETASIFSICVISYDRLKQVQKPLHY
EEFMTTTRALLIIACLWICSFVLSFVPIFLEWHELSVEEIKakSNAKHVCLFDVHFTYSVIYSFICFYVP
CTLMLTNYLRLFLIAQTHQVRIRSLqrGQGASSYRNQGTQGSKAARTLTIITGTFLACWLPFFIINPIAA
ADEHLIPLECFMVTIWLGYFNSSVNPIIYGTSNSKFRAAFKRLLRCRSVKSVVGSIS----
>214:P35372 Mu-type opioid receptor OS=Homo sapiens OX=9606 GN=OPRM1 PE=1 SV=2 2 224 3e-69 1 90.6% 23.8% 2:324 33:353
-NLSHLDGNLSDPCGPNRTdcPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIY
IFNLALADAL-ATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKA
LDFRTPRNAKIINVCNWILSSAIGLPVMF-MATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMP
VLIITVCYGLMILRLKSVRMLSGSKEKDRNL----------RRITRMVLVVVAVFIVCWTPIHIYVIIKA
LV--TIPETTFQTVSwlGYTNSCLNPVLYAFLDENFKRCFREFC-----------------
>215:P46616 Adenosine receptor A2a OS=Cavia porcellus OX=10141 GN=ADORA2A PE=2 SV=1 2 224 4e-69 1 87.7% 27.4% 31:333 2:309
------------------------------SSSVYITVELVIAVLAILGNVLVCWAVWINSNLQNVTNYF
VVSLAAADIAVGVLAIPFAITISTGFC--AACHGCLFFACFVLVLTQSSIFSLLTITIDRYIAIRIPLRY
NGLVTCTRAKGIIAICWVLSFAIGLTPMLGWNNCsnHSESCDEGQVTCLFEDVVPMNYMVYYNFFAFVlp
LLLMLGIYLRIFLAARRQLKQME--SQPLPGERTRSTLQKEVHPAKSLAIIVGLFALCCLPLNIINCFTF
FCPECdpPWLMYLTIILSHGNSVVNPLIYAYRIREFRQTFRKIIRSHILRRRE--------
>216:P49660 Somatostatin receptor type 4 OS=Mus musculus OX=10090 GN=Sstr4 PE=1 SV=2 2 224 4e-69 1 83.0% 25.9% 33:329 45:328
--------------------------------VTIQCIYALVCLVGLVGNALVIFVILRYAKMKTATNIY
LLNLAVADELFMLSV-PFARSAAALRHWPFGAVLCRAVLSVDGLNMFTSVFCLTVLSVDRYVAVVHPLAT
ATYRRPSVAKLINLGVWLASLLVTLPIAVFADTRPA--RGGEAVACNLHWPHpwSAVFVIYTFLLGFLPP
VLAIGLCYLLI--VGKMRAVALAGGWQQRRR--------SEKKITRLVLMVVTVFVLCWMPFYVVQLLNL
FVT-SLDATVNHVSLILSYANSCANPILYGFLSDNFRRSFQRVLCLRCC------------
>217:Q5IS39 Mu-type opioid receptor OS=Pan troglodytes OX=9598 GN=OPRM1 PE=2 SV=1 2 224 4e-69 1 90.6% 23.8% 2:324 34:354
-NLSHLDGNLSDPCGPNRTdcPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIY
IFNLALADAL-ATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKA
LDFRTPRNAKIINVCNWILSSAIGLPVMF-MATTKYRHGSIDCTLTFSHPTWYWENLLKICVFIFAFIMP
VLIITVCYGLMILRLKSVRMLSGSKEKDRNL----------RRITRMVLVVVAVFIVCWTPIHIYVIIKA
LV--TIPETTFQTVSwlGYTNSCLNPVLYAFLDENFKRCFREFC-----------------
>218:Q60483 Beta-3 adrenergic receptor (Fragment) OS=Cavia porcellus OX=10141 GN=ADRB3 PE=2 SV=1 2 222 4e-69 1 89.1% 34.2% 8:317 15:351
-------PDTPTLAPNTANTSGLPGVPWAAALAG-----ALLALATVGGNLLVIVAIACTPRLQTMTNVF
VTSLAAADLVVGLLVVPPGATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRY
RAVVTKRRARAAVALVWAVAAAVSFAPIMSQWWRAGADAEAQLCHGNPRCCAFvnVPYALLSSSVSFYLP
LLVMLFVYARVFLVAQRQLRLLREEVGRFPPQGSPRIRsrERRALRTLGLIVGTFALCWLPFFLANVLRA
LGGPsvPNSVLLPLNWLGYVNSAFNPLIY-CRSPDFR------------------------
>219:P30680 Somatostatin receptor type 2 OS=Rattus norvegicus OX=10116 GN=Sstr2 PE=1 SV=1 2 223 5e-69 1 92.4% 23.9% 1:326 1:329
MELTSEQFNGSQVWIppSNGSNQTEPYymTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIY
ILNLAIADELFML-GLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKS
AKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVP
LTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKK----------VTRMVSIVVAVFIFCWLPFYIFNVSSV
SVAISPTPAlfDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCL---------------
>220:P14842 5-hydroxytryptamine receptor 2A OS=Rattus norvegicus OX=10116 GN=Htr2a PE=1 SV=1 2 225 6e-69 1 89.7% 28.3% 28:341 70:411
---------------------------HLQEKNWSALLTTVVIILTIAGNILVIMAVSLEKKLQNATNYF
LMSLAIADMLLGFLVMPVSMLTILYGywPLPSKLCAIWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHH
SRFNSRTKAFLKIIAVWTISVGISMPI-----PVFGLQD-DSKVFKEGSCLLADDNF-VLIGSFVAFFIP
LTIMVITYFLTIKSLQKEarSIHREPGSYAGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAV
ICKESciGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQ-YKENRKPLQLILV
>221:Q4U4D2 Melanopsin OS=Podarcis siculus OX=65484 GN=OPN4 PE=2 SV=2 2 225 7e-69 1 86.5% 22.5% 39:340 23:325
--------------------------------------VLVIGSIGITGNLLVLYAFYSNKRLRTPANYF
IMNLAASDFLMSATQAPICFLNSMHTEWILGDIGCNFYVFCGALFGITSMMTLLAISVDRYCVITKPLQS
IKRSSKKRSCIIIAFVWLYSLGWSVCPLF------GWSSYIPeiSCTWDYVSYsnRSYTMMLCCFVFFIP
LIIIFHCYLFMFLAIRSTGRNVQKLGSTYNRKSNVSQskSEWKLAKIAFVAIVVFVLSWSPYACVTLIAw
yAKTLNPYSK-SVPAVIAKASAIYNPIIYAIIHPRYRRTIRSAVPCLRFLIRISPSDLST-
>222:Q2KNE5 Melanopsin-A OS=Danio rerio OX=7955 GN=opn4a PE=2 SV=3 2 228 1e-68 1 84.5% 22.6% 35:326 78:371
----------------------------------IGAVILTVGITGMLGNFLVIYAFSRSRTLRTPANLF
IINLAITDFLMCATQAPIFFTTSMHKRWIFGEKGCELYAFCGALFGICSMITLMVIAVDRYFVITRPLAS
IGVLSQKRALLILLVAWVYSLGWSLPPFFGwyVPEGLLTSCTWDYMTFTPSV---RAYTMLLFIFVFFIP
LIVIIYCYFFIFRSIRTTNEAVGKINgkRDSMKRFQRLKNEWKMAKIALIVILMYVISWSPYSTVAlfAG
YSDFLTPY-MNSVPAVIAKASAIHNPIIYAITHPKYRLAIAKYIPC---------------
>223:P34975 Kappa-type opioid receptor OS=Rattus norvegicus OX=10116 GN=Oprk1 PE=2 SV=1 2 222 1e-68 1 83.0% 24.1% 28:321 55:342
---------------------------SPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIY
IFNLALADALVT-TTMPFQSAVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKA
LDFRTPLKAKIINICIWLlsVGISAIVLGGTKVREDVDVIECSLQFPDDEYSWWDLFMKICVFVFAFVIP
VLIIIVCYTLMILRLKSVRLLSGSREKDRNL----------RRITKLVLVVVAVFIICWTPIHIFILVEA
LGSTSHSTAvyYFCIALGYTNSSLNPVLYAFLDENFKRCFR--------------------
>224:P09241 Rhodopsin OS=Enteroctopus dofleini OX=267067 GN=RHO PE=2 SV=1 2 224 2e-68 1 87.7% 23.4% 35:337 38:349
----------------------------------VGIFIGVVGIIGILGNGVVIYLFSKTKSLQTPANMF
IINLAMSDLSFSAigFPLKTISAFMKKWIFGKVACQLYGLLGGIFGFMSINTMAMISIDRYNVIGRPMAA
SKKMSHRRAFLMIIFVWMWSIVWSVGPVFNWGapEGILTSCSFDYLSTDPS---TRSFILCMYFCGFMLP
IIIIAFCYFNIVMSVSNHEKEMAAMAKRLNAKELRKAqsAEMKLAKISMVIITQFMLSWSPYAIIALLAQ
faEWVTPYAA-ELPVLFAKASAIHNPIVYSVSHPKFREAIqlLTCCQFDEKECEDAN----
>225:Q8IN35 Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2 2 231 2e-68 1 93.8% 22.6% 5:332 176:517
----TKSYNDSALRWEQLDGSVDFGfhSLAMSMVYCVAYIVVFLVGLIGNSFVIAVVLRAPRMRTVTNYF
IVNLAIADILVIVFCLPATLIGNIFVPWMLGWLMCKFVPYIQGVSVAASVYSLIAVSLDRFIAIWWPLK-
--QMTKRRARIMIIGIWVIALVTTIPWLLfvPAEEVFSDALVSAYSQPqcQEVWpnLYFLLANLvcYLLP
MSLITLCYVLIWIKVSTR----SIPGESKDAQMDRMQQKSKVKVIKMLVAVVILFVLSWLPLYVIFARIK
FgeFEILKKVMPVAQWLGSSNSCINPILYS-VNKKYRRGFAAIIKSRSCCGR---------
>226:P35363 5-hydroxytryptamine receptor 2A OS=Mus musculus OX=10090 GN=Htr2a PE=1 SV=1 2 224 2e-68 1 89.7% 28.3% 28:341 70:411
---------------------------HLQEKNWSALLTTVVIILTIAGNILVIMAVSLEKKLQNATNYF
LMSLAIADMLLGFLVMPVSMLTILYGywPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHH
SRFNSRTKAFLKIIAVWTISVGISMPI-----PVFGLQD-DSKVFKEGSCLLADDNF-VLIGSFVAFFIP
LTIMVITYFLTIKSLQKEarSIHREPGSYAGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAV
ICKESciGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQ-YKENRKPLQLILV
>227:Q9GK74 Neuropeptide Y receptor type 2 OS=Macaca mulatta OX=9544 GN=NPY2R PE=2 SV=1 2 221 3e-68 1 92.1% 22.2% 2:326 20:342
-EQYGPQTTPRGELVPDPEPELIDSTKLIEVQVVLILAYCSIILLGVIGNSLVIHVVIKFKSMRTVTNFF
IANLAVADLVVNTLCLPFTLTYTLMGEWKMGPVLCHLVPYAQGLAVQVSTITLTVIALDRHRCIVYHLE-
-SKISKRISFLIIGLAWGISALLASPliFREYSLIEIIPDFEIVACTEKWpsIYGTVYSLSSLLILYVLP
LGIISFSYTRIWSKLKSHVSPGAANDHYHQ---------RRQKTTKMLVCVVVVFAVSWLPLHAFQLasH
VLDLKEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRC---------------
>228:P33534 Kappa-type opioid receptor OS=Mus musculus OX=10090 GN=Oprk1 PE=1 SV=1 2 221 3e-68 1 83.0% 24.1% 28:321 55:342
---------------------------SPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIY
IFNLALADALVT-TTMPFQSAVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKA
LDFRTPLKAKIINICIWLlsVGISAIVLGGTKVREDVDVIECSLQFPDDEYSWWDLFMKICVFVFAFVIP
VLIIIVCYTLMILRLKSVRLLSGSREKDRNL----------RRITKLVLVVVAVFIICWTPIHIFILVEA
LGSTSHSTAayYFCIALGYTNSSLNPVLYAFLDENFKRCFR--------------------
>229:P79350 Mu-type opioid receptor OS=Bos taurus OX=9913 GN=OPRM1 PE=2 SV=2 2 221 4e-68 1 90.6% 24.1% 2:324 34:354
-NFSHLEGNLSDPCGPNRTecPSAGSPSMITAIIIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIY
IFNLALADAL-ATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKA
LDLRTPRNAKIINICNWILSSAIGLPVMF-MATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMP
ILIITVCYGLMILRLKSVRMLSGSKEKDRNL----------RRITRMVLVVVAVFIVCWTPIHIYVIIKA
LI--TIPETTFQTVSwlGYTNSCLNPVLYAFLDENFKRCFREFC-----------------
>230:P30549 Substance-K receptor OS=Mus musculus OX=10090 GN=Tacr2 PE=2 SV=1 2 220 6e-68 1 97.1% 22.2% 1:338 1:336
MGAHASVTDTNILSGLESNATGVTAFSMPGWQLALwtAYLALVLVAVTGNATVIWIILAHERMRTVTNYF
IINLALADLCMAAFNATFNFIYASHNIWYFGSTFCYFQNLFPVTAMFVSIYSMTAIAADRYMAIVHPFQ-
-PRLSAPSTKAVIAVIWLVALALASPQCFYSTITVDQGATKCVVAWPNDNGGKMLLLYHLVVFVLIYFLP
LVVMFAAYSVIGLTLWKRA-----VPRHQAHGANLRHLQAKKKFVKAMVLVVVTFAICWLPYHLYFILGT
FQEdkFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWGTPTEEDRL---
>231:P11615 Alpha-1B adrenergic receptor (Fragment) OS=Canis lupus familiaris OX=9615 GN=ADRA1B PE=2 SV=1 2 221 6e-68 1 69.2% 33.2% 85:328 1:270
----------------------------------------------------------------------
--------------VLPFSAALEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQY
PTLVTRRKAILALLGVWVLSTVISIGPLLGWKEPAPNDD--------KECGVTEEPFYALFSSLGSFYIP
LAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELtfSREKKAAKTLGIVVGMFILCWLPFFIAllGSL
FSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFVRILGCQC-------------
>232:P30731 Probable G-protein coupled receptor 83 OS=Mus musculus OX=10090 GN=Gpr83 PE=2 SV=2 2 222 6e-68 1 90.0% 25.2% 25:338 64:374
------------------------ESQNPTVKALLIVAYSFTIVFSLFGNVLVCHVIFKNQRMHSATSLF
IVNLAVADIMITLLNTPFTLVRFVNSTWVFGKGMCHVSRFAQYCSLHVSALTLTAIAVDRHQVIMHPLK-
-PRISITKGVIYIAVIWVMATFFSLpaICQKLFTFKYSEDIVRSLCLPDFPEPADLFWKYltFILLYLLP
LFIISVAYAR---VAKKLWLCNTIGDVTTEQYLALRR--KKKTTVKMLVLVVVLFALCWFPLNCYVLLLS
SKAIHTNNALYFAFHWFAMSSTCYNPFIYCWLNENFRVELKALLSMCQRPPKPQEDRL---
>233:P79113 Neuropeptide Y receptor type 2 OS=Bos taurus OX=9913 GN=NPY2R PE=2 SV=1 2 220 8e-68 1 88.0% 23.2% 16:326 37:345
---------------PDSEPELIDSTKLIEVQVVLILAYCSIILLGVIGNSLVIHVVIKFKSMRTVTNFF
IANLAVADLLVNTLCLPFTLTYTLMGEWKMGPVLCHLVPYAQGLAVQVSTITLTVIALDRHRCIVYHLE-
-SKISKQISFLIIGLAWGVSALLASPliFREYSLIEIIPDFEIVACTEKWpgIYGTIYSLSSLLILYVLP
LGIISFSYTRIWSKLKNHVSPGAAHDHYHQ---------RRQKTTKMLVCVVVVFAVSWLPLHAFQLasH
VLDLKEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRC---------------
>234:P30975 Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2 2 224 1e-67 1 89.1% 27.2% 29:340 98:417
----------------------------WWRQVLWSILFGGMVIVATGGNLIVVWIVMTTKRMRTVTNYF
IVNLSIADAMVSSLNVTFNYYYMLDSDWPFGEFYCKLSQFIAMLSICASVFTLMAISIDRYVAIIRPLQ-
-PRMSKRCNLAIAAVIWLASTLISCPMMieEVPVRGlnRTVCYPEWPDGPTNhmESLYNILIIILTYFLP
IVSMTVTYSRVGIELW-GSKTIGECTPRQVENV-----RSKRRVVKMMIVVVLIFAICWLPFhiTSCYPA
ITEAPFIQELYLAIYWLAMSNSMYNPIIYCWMNSRFRYGFKMVFRWCLfePFSRRENLTS-
>235:P31391 Somatostatin receptor type 4 OS=Homo sapiens OX=9606 GN=SSTR4 PE=2 SV=2 2 220 1e-67 1 85.6% 26.1% 24:329 39:331
-----------------------PGDARAAGMVAIQCIYALVCLVGLVGNALVIFVILRYAKMKTATNIY
LLNLAVADELFMLSV-PFVASSAALRHWPFGSVLCRAVLSVDGLNMFTSVFCLTVLSVDRYVAVVHPLRA
ATYRRPSVAKLINLGVWLASLLVTLPIAIFADTRPA--RGGQAVACNLQWPHpwSAVFVVYTFLLGFLLP
VLAIGLCYLLI--VGKMRAVALRAGWQQRRR--------SEKKITRLVLMVVVVFVLCWMPFYVVQLLNL
FVT-SLDATVNHVSLILSYANSCANPILYGFLSDNFRRFFQRVLCLRCC------------
>236:P30875 Somatostatin receptor type 2 OS=Mus musculus OX=10090 GN=Sstr2 PE=2 SV=1 2 219 2e-67 1 92.4% 23.6% 1:326 1:329
MEMSSEQLNGSQVWvgPSNGSNQTEPYymTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIY
ILNLAIADELFML-GLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKS
AKWRRPRTAKMINVAVWCVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVP
LTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKK----------VTRMVSIVVAVFIFCWLPFYIFNVSSV
SVAISPTPAlfDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCL---------------
>237:Q28838 Alpha-2A adrenergic receptor OS=Bos taurus OX=9913 GN=ADRA2A PE=2 SV=2 2 221 2e-67 1 72.7% 23.4% 2:253 3:250
-SLQPDAGNASWNGTEAPGGGARATPYSLQVTLTLVCLAGLLMLFTVFGNVLVIIAVFTSRALKAPQNLF
LVSLASADILVATLVIPFSLANEVMGYWYFGKAWCEIYLALDVLFCTSSIVHLCAISLDRYWSITQAIEY
NLKRTPRRIKAIIVTVWVISAVISFPPLISFEKKRGRS---GQPSAEPRCEINDQKWYVISSSIGSFFAP
CLIMILVYVRIYQIAKRRTR-VPPSRRGPDATAAELPGSAERR---------------------------
-------------------------------------------------------------
>238:Q95247 Mu-type opioid receptor OS=Sus scrofa OX=9823 GN=OPRM1 PE=2 SV=1 2 219 2e-67 1 84.8% 24.1% 22:324 61:354
---------------------PPTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIY
IFNLALADAL-ATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKA
LDFRTPRNAKIINVCNWILSSAIGLPVMF-MATTKYRNGSIDCALTFSHPTWYWENLLKICVFIFAFIMP
VLIITVCYGLMILRLKSVRMLSGSKEKDRNL----------RRITRMVLVVVAVFIVCWTPIHIYVIIKA
LI--TIPETTFQTVSwlGYTNSCLNPVLYAFLDENFKRCFREFC-----------------
>239:P21452 Substance-K receptor OS=Homo sapiens OX=9606 GN=TACR2 PE=1 SV=3 2 219 3e-67 1 92.7% 22.6% 16:338 16:336
---------------PESNTTGITAFSMPSWQLALwtAYLALVLVAVTGNAIVIWIILAHRRMRTVTNYF
IVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQ-
-PRLSAPSTKAVIAGIWLVALALASPQCFYSTVTMDQGATKCVVAWPEDSGGKTLLLYHLVVIALIYFLP
LAVMFVAYSVIGLTLWRRA-----VPGHQAHGANLRHLQAMKKFVKTMVLVVLTFAICWLPYHLYFILGS
FQehKFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTKEDKL---
>240:P31387 5-hydroxytryptamine receptor 5B OS=Mus musculus OX=10090 GN=Htr5b PE=2 SV=1 2 218 3e-67 1 81.5% 27.7% 43:327 63:369
------------------------------------------IAATFLWNLLVLVTILRVRAFHRVPHNL
VASTAVSDVLVAVLVMPLSLVSELsrRWQLGRSLCHVWISFDVLCCTASIWNVAAIALDRYWTITRHLQY
TLRTRSRASALMIAITWALSALIALAPL-----LFGWGE--AYDARLQRCQVSQEPSYAVFSTCGAFYLP
LAVVLFVYWKIYKAAkrRRRAVVPLPATTQAKEAPprEQKEKRAAMMVGILIGVFVLCWIPFFLTELISP
LCACSLPPIWKSIFLWLGYSNSFFNPLIYTAFNKNYNNAFKSLFTKQ--------------
>241:P16610 Substance-K receptor OS=Rattus norvegicus OX=10116 GN=Tacr2 PE=2 SV=1 2 219 3e-67 1 86.5% 23.5% 37:338 38:336
------------------------------------TAYLALVLVAVTGNATVIWIILAHERMRTVTNYF
IINLALADLCMAAFNATFNFIYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQ-
-PRLSAPSTKAIIAGIWLVALALASPQCFYSTITVDEGATKCVVAWPNDNGGKMLLLYHLVVFVLIYFLP
LLVMFGAYSVIGLTLWKRA-----VPRHQAHGANLRHLQAKKKFVKAMVLVVLTFAICWLPYHLYFILGT
FQehKFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTEEDRL---
>242:P35365 5-hydroxytryptamine receptor 5B OS=Rattus norvegicus OX=10116 GN=Htr5b PE=2 SV=1 2 218 3e-67 1 81.5% 29.5% 43:327 63:369
------------------------------------------IAATFLWNLLVLVTILRVRAFHRVPHNL
VASTAVSDVLVAALVMPLSLVSELsrRWQLGRSLCHVWISFDVLCCTASIWNVAAIALDRYWTITRHLQY
TLRTRRRASALMIAITWALSALIALAPL-----LFGWGE--AYDARLQRCQVSQEPSYAVFSTCGAFYVP
LAVVLFVYWKIYKAAKFRFGRRRRaaPQESETVFTARcqKEKRAAMMVGILIGVFVLCWIPFFLTELVSP
LCACSLPPIWKSIFLWLGYSNSFFNPLIYTAFNKNYNNAFKSLFTKQ--------------
>243:Q60474 Alpha-2A adrenergic receptor OS=Cavia porcellus OX=10141 GN=ADRA2A PE=3 SV=1 2 220 4e-67 1 72.4% 23.0% 2:253 3:249
-SLQPDSGNASWNGTEGPGGGTRATPYSLQVTVTLVCLVGLLILLTVFGNVLVIIAVFTSRALKAPQNLF
LVSLASADILVATLVIPFSLANEVMGYWYFGKAWCEIYLALDVLFCTSSIVHLCAISLDRYWSITQAIEY
NLKRTPRRIKAIIVTVWVISAVISFPPLISFEKAGGGGQQPAEPR----CEINDQKWYVISSSIGSFFAP
CLIMILVYVRIYQIAKRRTR-VPPSRRGPDAHAAAPPGGAERR---------------------------
-------------------------------------------------------------
>244:Q64077 Substance-K receptor OS=Cavia porcellus OX=10141 GN=TACR2 PE=2 SV=1 2 219 5e-67 1 92.4% 21.7% 17:338 17:336
----------------ESNTTGITAFSMPTWQLALwtAYLALVLVAVTGNATVTWIILAHQRMRTVTNYF
IVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAIDRYMAIVHPFQ-
-PRLSAPSTKAVIGGIWLVALALAFPQCFYSTITEDEGATKCVVAWPEDSRDKSLLLYHLVVIVLIYLLP
LTVMFVAYSIIGLTLWRRA-----VPRHQAHGANLRHLQAKKKFVKTMVLVVVTFAICWLPYHLYFILGS
FQehKFIQQVYLALFWLAMSSTMYNPIIYCCLNRRFRSGFRLAFRCCPWVTPTEEDKL---
>245:P79218 Substance-K receptor OS=Oryctolagus cuniculus OX=9986 GN=TACR2 PE=2 SV=1 2 218 5e-67 1 86.5% 23.2% 37:338 38:336
------------------------------------TAYLALVLVAVVGNATVIWIILAHRRMRTVTNYF
IVNLALADLCMATFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQ-
-PRLSGPGTKAVIAGIWLVALALAFPQCFYSTITMDQGATKCVVAWPEDSGGKMLLLYHLTVIALIYFLP
LVVMFVAYSVIGFKLWRR-----TVPGHQTHGANLRHLRAKKKFVKTMVLVVVTFAVCWLPYHLYFLLGH
FQDdkFIQQVYLVLFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTEEDKL---
>246:P30874 Somatostatin receptor type 2 OS=Homo sapiens OX=9606 GN=SSTR2 PE=1 SV=1 2 217 6e-67 1 84.8% 23.3% 27:326 38:329
--------------------------YDLTSNAVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITNIY
ILNLAIADELFML-GLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKS
AKWRRPRTAKMITMAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYTFILGFLVP
LTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKK----------VTRMVSIVVAVFIFCWLPFYIFNVSSV
SMAISPTPAlfDFVVVLTYANSCANPILYAFLSDNFKKSFQNVLCL---------------
>247:Q5IS66 5-hydroxytryptamine receptor 2C OS=Pan troglodytes OX=9598 GN=HTR2C PE=2 SV=1 2 220 7e-67 1 85.0% 27.4% 31:326 52:385
------------------------------VQNWPALSIVVIIIMTIGGNILVIMAVSMEKKLHNATNYF
LMSLAIADMLVGLLVMPLSLLAILYDywPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEH
SRFNSRTKAIMKIAIVWAISIGVSVPI-----PVIGLRDERKVFVNNTTCVLN-DPNFVLIGSFVAFFIP
LTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLsmQAINNERKASKVLGIVFFVFLIMWCPFFITNILSV
LCEKScmEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRC---------------
>248:Q9DDN6 Neuropeptide Y receptor type 2 OS=Gallus gallus OX=9031 GN=NPY2R PE=3 SV=1 2 217 8e-67 1 85.6% 24.1% 24:326 46:346
-----------------------DSTTLVEVQIILIFAYCSIILLGVIGNSLVIHVIIKFKSMRTVTNFF
IANLAVADLLVNTLCLPFTLVYTLLGEWKLGPVLCHLVPYAQALAVHVSTVTLTVIALDRHRCIVYHLE-
-SKISKRISFLIIGVAWAVSALLASPliFREYSLIEIIPDFKIVVCSEKWplNYGTIYSVSMLLIQYVLP
LAIISYAYTRIWTKLKNHVSPGAG---------NDHYHHRRQKTTKMLVCVVVVFAVSWLPFHAFQLvsQ
VLDLKEYKLIYTVFHVIAMCSTFANPLLYGWMNNNYRTAFLTAFQC---------------
>249:P41143 Delta-type opioid receptor OS=Homo sapiens OX=9606 GN=OPRD1 PE=1 SV=4 2 217 9e-67 1 94.4% 22.5% 4:337 18:346
---NASDAYPSACPSAGANASGPPGARslALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIY
IFNLALADAL-ATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKA
LDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRP-RDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVP
ILIITVCYG----------LMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWT
LVDIdlVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFS----
>250:Q13585 Melatonin-related receptor OS=Homo sapiens OX=9606 GN=GPR50 PE=1 SV=3 2 224 1e-66 1 83.3% 22.7% 27:325 23:310
--------------------------YPPALIIFMFCAMVITIVVDLIGNSMVILAVTKNKKLRNSGNIF
VVSLSVADMLVAIYPYPLMLHAMSIGGWDLSQLQCQMVGFITGLSVVGSIFNIVAIAINRYCYICHSLQY
ERIFSVRNTCIYLVITWIMTVLAVLPNMY-----IGTIEYDPRTY-TCIFNYLNNPVFTVTIVCIHFVLP
LLIVGFCYVRIWTKVLAARDPAGQNPDNQ---------LAEVRNFLTMFVIFLLFAVCWCPINVLTVLVA
vmAGKIPNWLYLAAYFIAYFNSCLNAVIYGLLNENFRREYWTIFH----------------
